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Abstract 
 
Abstract 
Recently we described a mechanism of gap junction-mediated communication between 
infected and uninfected epithelial cells that potentiates innate immunity during infection 
by the enteroinvasive bacterium Shigella flexneri. We showed that although S. flexneri 
secretes multiple effector proteins that downregulate inflammation in infected epithelial 
cells, NF-κB and the MAP kinases p38, JNK and ERK are activated in uninfected cells 
surrounding the sites of infection. The propagation of these proinflammatory signals 
leads to massive secretion of proinflammatory cytokines such as interleukin-8 (IL-8) by 
uninfected bystander cells. A genome wide RNAi-screen on Shigella-induced bystander 
activation confirmed the roles of the proteins TAK1 and NF-κB. Besides this, new 
candidates for bystander activation were found, including Na+/K+-ATPase (ATP1A1), 
the TRAF-interacting protein with a FHA domain (TIFA) and the TNF receptor-
associated factor 6 (TRAF6). These proteins together with NOD1 and RIPK2, members 
of the NOD1 signaling pathway, which is induced by invasive Shigella, were studied in 
more detail. To our surprise we found that signals underlying cell-cell communication 
are produced independently of the receptor NOD1 and the downstream signaling 
proteins RIPK2, TAK1 and NF-κB as well as independent of TIFA and TRAF6. 
Unexpectedly, in bystander cells NOD1 and RIPK2 contribute to the proinflammatory 
response, whereas TAK1, NF-κB, TIFA and TRAF6 are indispensable for the 
production of cytokines. Furthermore, TIFA and TRAF6 are upstream of TAK1 and are 
required for TAK1 activation. In addition, selective stimulation of TIFA or TRAF6 
depleted cells with the NOD1 ligand iE-DAP unraveled that TIFA and TRAF6 contribute 
to NOD1 signaling in bystander cells of S. flexneri infection. And finally, we propose a 
link between intercellular calcium signaling triggered by invasive S. flexneri and 
bystander IL-8 expression, since inhibition of calcium signals via a calcium chelator or 
inhibition of the IP3-receptor or phospholipase C (PLC) lead to a decreased bystander 
IL-8 response. 
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1 Shigella causative agent of shigellosis and model 
organism to study host pathogen interactions 
1.1 Shigellosis or acute bacillary dysentery 
Shigellosis or bacillary dysentery is a global human health problem especially in 
developing countries, with poor hygiene and bad water supplies. However, shigellosis 
also occurs in industrialized countries where children in day-care centers, travelers, 
migrant workers or persons infected with HIV most often are affected. In 1999, it was 
estimated that annually more than 165 million Shigella episodes occur worldwide, with 
99% occurring in developing countries. 1.1 million deaths were attributed to Shigella 
infections annually. The highest incidence and case-fatality rates were found in children 
below the age of five years [1]. Recently, by reviewing the literature from 1990 to 2009, 
a similar incidence rate was found for shigellosis but the number of cases with fatal 
outcome was 98% lower compared to the earlier estimate. The authors of the new 
study speculate that nonspecific interventions including measles vaccination, vitamin A 
supplementation and improved nutrition could be the reason for the reduced number of 
deaths in shigellosis patients [2]. However, shigellosis remains a global health burden 
due to the high incidence rate and the emerging number of multi-drug resistant Shigella 
strains [3]. 
Bacillary dysentery is caused by Shigella species that are highly adapted to primates 
and humans. The genus Shigella belongs to the family of Enterobacteriaceae. There 
are four major species of Shigella classified by biochemical, antigenetic and clinical 
characteristics: S. dysenteriae, S. flexneri, S. boydii and S. sonnei [4]. The majority of 
all infections is caused by S. flexneri and S. sonnei, whereas S. dysenteriae is 
responsible for the most severe form of dysentery and therefore causes the majority of 
fatal shigellosis cases. 
Bacteria are transmitted directly via the feco-oral route or indirectly through 
contaminated water or food. The pathogen is highly contagious, as few as 100 
microorganisms are sufficient to cause the disease [5]. Shigella species invade the 
human colon and rectum where they cause an acute mucosal inflammation. Patients 
suffer from diarrhea, mucoid bloody stool, fever and abdominal cramps. Shigellosis is 
usually a self-limited illness. But depending on the virulence potential of the strain and 
the nutritional status of the individual, shigellosis can progress to severe disease [6]. 
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Even though, oral rehydration would be sufficient as therapy, an additional antibiotic 
treatment is advantageous and recommended by the World Health Organisation (WHO 
2005) guidelines [7]. On one hand it shortens the duration of the disease, in serious 
cases it might be life-saving and the spreading of the disease can be limited. A major 
problem, however, is the increasing number of multidrug-resistant Shigella strains [8]. 
Therefore, an effective Shigella spp. vaccine may have substantial benefits, but so far 
there is no vaccine available. 
1.2 Cellular pathogenesis of Shigella infections 
Shigella spp. are enteroinvasive, gram-negative, rod-shaped, non-motile, uncapsulated, 
and facultative anaerob bacteria that belong to the family Enterobacteriaceae. Shigella 
spp. evolved from non-pathogenic E. coli by the acquisition of a large virulence plasmid 
and chromosomal pathogenicity islands (PAI). Comparative genomics between E. coli 
K-12 and Shigella spp. revealed sequence differences of about 1.5% only. To date the 
complete sequences of the virulence plasmids and the chromosomes of various 
Shigella strains are available [9]. 
The PAIs together with the virulence plasmid encoded genes are responsible for the 
invasive phenotype of Shigella spp.. These genes allow Shigella to kill macrophages, to 
invade intestinal epithelial cells (IECs) and to trigger the acute inflammation response 
typical for shigellosis. pWR100, the 213-kb virulence plasmid of S. flexneri strain M90T 
(serotype 5) harbors about 100 genes and many insertion sequences [10]. The core of 
the plasmid is the conserved 31-kb entry region, where genes are clustered, that are 
required and sufficient to invade IECs and to induce pyroptosis in macrophages. This 
gene cluster encodes for Mxi and Spa proteins that are required for assembly and 
regulation of the type 3 secretion system (T3SS), the transcription factors VirB and 
MxiE, chaperones (IpgA, IpgC, IpgE, and Spa15), the translocators IpaB and IpaC and 
the secreted effector proteins (IpaD, IpgB1, IpgD and IcsB) [11-13]. Other substrates of 
the T3SS are encoded by genes scattered throughout the virulence plasmid and are 
listed in Table I.1. 
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Table I.1 S. flexneri T3SS translocated effectors encoded on the virulence plasmid. 
Effector 
 
Biochemical 
activity 
Host cell target(s) 
 
Virulence function and/or 
phenotype 
IpaA Vinculin activation Vinculin, β1-integrins, Rho 
signaling 
Efficient invasion, actin 
cytoskeleton rearrangements, 
disassembly of cell-matrix 
adherence 
IpaB Membrane fusion Cholesterol, CD44, 
caspase-1 
Control of type III secretion, 
translocon formation, phagosome 
escape, macrophage apoptosis 
IpaC Actin 
polymerization 
Actin, β-catenin Translocon formation, filopodium 
formation, phagosome escape, 
disruption of EC tight junctions 
IpaD   Control of type III secretion, 
membrane insertion of translocon 
IpaH7.8   Efficient phagosome escape 
IpaH9.8 E3 ubiquitin ligase Splicing factor U2AF, 
MAPK kinase, NEMO/IKKγ 
ABIN-1, NF-κB pathway 
Host cell transcriptome 
modulation, reduction of 
inflammation 
IpaH0722 E3 ubiquitin ligase TRAF2 Inhibition of NF-κB activation, 
dampening of inflammatory 
response 
IpaJ Cysteine protease ARF1 Inhibition of Golgi cargo transport, 
Golgi fragmentation 
IcsA 
(VirG) 
 N-WASP, vinculin Recruitment of actin-nucleating 
complex required for actin-based 
motility and intercellular spread 
IcsB  Atg5 Camouflage of IcsA for 
autophagic evasion 
IcsPa Serine protease  Cleavage of IcsA, modulation of 
actin-based motility 
IpgB1 RhoG mimicry ELMO protein Induction of Rac1-dependent 
membrane ruffling, regulation of 
inflammation 
IpgB2 RhoA mimicry RhoA ligands Induction of actin stress fiber-
dependent membrane ruffling 
IpgD Phosphoinositide 4-
phosphatase 
Phosphatidylinositol 4,5-
bisphosphate, leads to 
connexin hemichannel 
blockage 
Facilitation of entry, promotion of 
host cell survival, prevents 
termination of EGFR signaling, 
down-regulates inflammation  by 
preventing ATP secretion 
OspB  Retinoblastoma Protein, 
GEF-H1, NF-κB pathway 
Reduction of inflammation 
OspC1  Nucleus and cytoplasm Induction of PMN migration 
OspC3 Caspase-4 binding, 
prevents  p19/p10 
heterodimerization 
Caspase-4 Reduction of cell death, increased 
bacterial replication 
Table I.1 Continued on next page 
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Effector 
 
Biochemical 
activity Host cell target(s) 
Virulence function and/or 
phenotype 
OspD1   T3SS substrate, unknown function in 
host cells, antiactivator of MxiE 
OspE1/E2  ILK, Focal contacts Maintenance of EC morphology, 
stabilization of focal adhesion 
OspF Phosphothreonine 
lyase 
MAPKs Erk and p38 Inhibition of histone phosphorylation 
and NF-κB-dependent gene 
expression, reduction of PMN 
recruitment 
OspG Protein kinase, 
ubiquitination 
inhibitor 
Ubiquitin-conjugating 
enzymes 
Downregulation of NF-κB activation, 
reduction of inflammation 
OspI Glutamine 
deamidase 
Ubiquitin-conjugating 
enzymes 
Downregulation of NF-κB activation, 
reduction of inflammation 
OspZ  NF-κB blockage of NF-κB subunit p65 
nuclear translocation, downregulation 
of IL-8 expression, redcues PMN 
transepithelial migration 
PhoN2a Apyrase  Unipolar localization of IcsA 
SepAa Serine protease  Promotion of intestinal tissue 
invasion and destruction 
VirA Cysteine protease α-Tubulin Facilitation of entry and intracellular 
motility by degradation of 
microtubules, Golgi fragmentation 
Calpain activation, cell death 
Adapted with modifications from PhD Thesis from C. Schmutz. 
 
Contact with host cell membranes triggers the insertion of the translocators IpaB and 
IpaC into the host cell membrane, where they form a pore through which they are 
themselves exported together with other effector proteins [14-16]. Expression of the 
genes of the virulence plasmid is tightly regulated. The regulatory cascade is triggered 
in response to environmental changes such as temperature shift to 37°C after uptake 
by the host, pH, osmolarity and iron concentration [17-20]. Upon encountering such 
changes, the virulence plasmid encoded transcription factors VirF and VirB are 
expressed, which in turn induce the expression of the entry region and the first set of 
effector proteins (IpaA-D, IpgB1, IpgD, IcsB, OspC2-4, OspD1/2,OspB, OspF, OspC1 
and VirA) of the virulence plasmid [12, 17]. Increased transcription of the first set 
proteins during secretion triggers the expression of a second set of effectors (OspB, 
OspC1, OspE1/2, OspF, VirA, OspG and IpaH4.5/7.8/9.8) under the control of the 
transcription factor MxiE and the chaperone IpgC, acting as a co-activator [21]. 
Introduction 
7 
Once ingested Shigella species survive the acidic milieu of the stomach because they 
harbor acid resistance systems [22]. In addition, Shigella species are able to down-
regulate the expression of antimicrobial peptides in the intestine [23]. After passing the 
small intestine, Shigella spp. reach the colon and rectum. Since Shigella spp. are not 
able to effectively invade epithelial cells directly from the luminal side, invasion occurs 
through the basolateral pole of colonic epithelial cells [24]. In order to get access to the 
submucosal space Shigella spp. exploit microfold cells (M-cells), specialized epithelial 
cells in the follicular associated epithelium (FAE) that overlie lymphoid tissue [25, 26]. 
M-cells allow intact Shigella to traverse into the underlying subepithelial pocket where 
macrophages reside and phagocytose invading bacteria. Shigella escape from the 
phagosome, enter the macrophage cytosol, where they replicate and induce pyroptosis 
[27]. Prior to cell death, infected macrophages release large amounts of the 
proinflammatory cytokines interleukin-1β (IL-1β) and IL-18 through the direct activation 
of caspase-1 by Shigella [27, 28]. Secretion of these cytokines results in the acute and 
massive inflammatory response, a hallmark of shigellosis [29]. IL-18 induces an 
effective antibacterial response by attracting natural killer (NK) cells and by inducing the 
production of interferon γ (INF-γ). IL-1β release results in the recruitment of 
polymorphonuclear cells (PMNs) from the blood stream to the site of infection [30, 31]. 
PMNs are phagocytes that efficiently kill bacteria. Invading PMNs cross the epithelial 
layer and thereby disrupt the integrity of the epithelium. This, in turn, allows more 
lumenal bacteria to translocate into the subepithelial space [32] and gives Shigella 
access to the basolateral pole of epithelial cells [24]. By the use of the T3SS, Shigella 
delivers effector proteins into the host cell. One set of the translocated effectors 
interfere with cytoskeletal components, induce the formation of membrane ruffles that 
engulf the bacteria and lead to their macropinocytotic uptake [9]. After having lysed the 
phagosomal membrane, Shigella reach the host cell cytosol where they start to 
replicate. By means of actin based motility, they spread to neighboring cells [33, 34]. 
Infected IECs recognize Shigella mainly via the cytosolic pattern recognition receptor 
NOD1 [35]. Upon binding of peptidoglycan moieties released from replicating bacteria, 
NOD1 gets activated, which is followed by the activation of the NF-κB and MAPK 
signaling pathways resulting in the expression of proinflammatory genes [36, 37] (Table 
I.2). 
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Table I.2 Up-regulated genes in S. flexneri infected IECs. 
Category of genes Description of genes Fold increase* 
Chemokines and 
cytokines 
Interleukin-8 304.79 
CXCL1 133.74 
CCL20 38.67 
CXCL2 13.17 
TNF-α inducible protein A20 4.23 
CXCL3 3.12 
TNF-α[ρ] 3.06 
B94 protein 1.66 
Colony-stimulating 
factors 
GM-CSF 33.24 
IEX-1  1.88 
*Gene expression of S. flexneri infected CaCo-2 cells compared to 
gene expression in uninfected CaCo-2 cells. Adapted with 
modifications from [36] 
Amongst these genes, IL-8, another chemoattractant of PMNs, is highly expressed 
during Shigella infection [38]. Shigella use another set of effector proteins including 
OspF, OspG, OspI, OspZ, IpaH0722 and IpaH9.8 to interfere with host cell signaling 
cascades thereby dampening the inflammatory response in infected cells (described in 
more detail in section 2.3). Infected cells in turn, counteract the inhibitory effect of 
bacterial effector proteins by propagating inflammatory signals to uninfected bystander 
cells, which produce large amounts of proinflammatory cytokines, such as IL-8 
(described in detail in section 3.3) (Figure I.1) [39]. 
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1.3 Induction of pyroptosis in macrophages 
After having crossed the intestinal epithelial layer via M-cells, Shigella reaches the 
submucosal space where macrophages reside. Macrophages are phagocytes that take 
up and degrade cellular debris, foreign substances and invading pathogens. Several 
bacterial pathogens have developed different strategies to escape from macrophage 
killing. S. flexneri, for instance, kills macrophages and thereby gets access to the 
basolateral side of IECs, which comprise the replicative niche of Shigella. To do so, S. 
flexneri induces pyroptosis in macrophages. Pyroptosis is a form of programmed cell 
death (PCD) that is characterized by the activation of NLR inflammasomes, multi-
protein complexes described in more detail in section 2.1.2. Inflammasomes mediate 
the activation of caspase-1, which mediates the proteolytic maturation of the cytokines 
IL-1β and pro-IL-18 and induces pyroptotic cell death [40, 41]. Cytokine secretion is 
followed by a massive inflammation response including the attraction of PMNs to the 
site of infection. Invading PMNs destabilize the integrity of the intestinal epithelial barrier 
and favor Shigella invasion. 
1.4 Shigella adherence and uptake into intestinal epithelial 
cells 
Once released form dying macrophages, S. flexneri have access to the basolateral side 
of IECs. Here they adhere to host cells at the sites of lipid rafts [42], which are 
subdomains of the plasma membrane that contain high concentrations of cholesterol, 
sphingolipids and glycosphingolipids [43]. Furthermore, this lipid rafts contain clusters of 
specific receptor proteins, which are connected to the actin cytoskeleton and to proteins 
 
 
Figure I.1 Stages of Shigella flexneri infection. Lumenal bacteria traverse the colonic 
epithelial cell layer via endocytic M-cells that transcytose the bacteria into the submucosal 
space, where they are phagocytosed by macrophages. After escaping from the phagosome, 
Shigella induces pyroptosis in macrophages, leading to the release of the proinflammatory 
cytokines IL-1β and IL-18. Upon escape from dying macrophages, Shigella bacteria trigger their 
uptake into IECs, escape from the vacuole, replicate in the host cytosol and use actin based 
motility to spread to adjacent IECs. IECs sense bacteria via pattern recognition receptors that 
activate the NF-κB signaling pathway. The proinflammatory signals are propagated from infected 
to uninfected bystander cells, which produce large amounts of IL-8. The secreted cytokines from 
macrophages and IECs, IL-1β and IL-8, attract PMNs to the site of infection. PMNs phagocytose 
the bacteria and are responsible for the clearance of the infection. IL-18 stimulates NK cells to 
produce IFN-γ. Altogether contribute to the induction of the acute intestinal inflammation 
characteristic for shigellosis. IEC, intestinal epithelial cell; IFN-γ, interferon gamma; NK-cell, 
natural killer cell; PMN, polymorph nuclear cell. Adapted with modifications from PhD Thesis 
from C. Schmutz and from [9] 
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localized at the cytoplasmic side of the plasma membrane [44]. Thus, lipid rafts act as 
signaling platforms that control endocytosis, intracellular vesicle trafficking and 
activation of the immune response and apoptosis [45-48]. The CD44 hyaluronan and 
α5β1 integrin receptor, are two proteins that are clustered in lipid rafts and both are 
administered by S. flexneri for adhesion [49, 50]. IpaB interacts with CD44, whereas the 
α5β1 integrin receptor is bound by IpaB, IpaC and IpaD. Recently, the outer membrane 
protein IcsA, known to be required actin based motility, in addition, was found to 
function as an adhesin that was necessary and sufficient to promote contact with IECs 
[51]. So far, the host receptor for IcsA could not be identified. Contact with host cells 
induces T3SS dependent secretion of effector proteins into the host cell cytosol. The 
concerted action of pore-forming proteins and effectors triggers massive actin 
polymerization. This leads to the formation of large membrane protrusions that engulf 
the bacteria and allow the macro-pinocytotic internalization of bacteria into non-
phagocytic host cells. Reorganization of the eukaryotic actin cytoskeleton is controlled 
by small Rho GTPases (including RHOA, RHOG, CDC42 and RAC1) and tyrosine 
kinases (e.g. SRC family members). The S. flexneri effector IpgB1, by mimicking 
activated RhoG, activates the RAC1-ELMO-DOCK180 pathway leading to membrane 
ruffling [52]. IpgB2, by mimicking activated RhoA, mediates stress fibers and membrane 
ruffling [53]. However, its role in the invasion process of S. flexneri is not completely 
understood. The pore-forming protein IpaC of S. flexneri induces SRC-dependent actin 
nucleation and ruffle formation in the vicinity of the bacteria [54, 55]. Secreted IpaA 
binds to the cytoskeleton associated protein vincullin, thus promoting depolymerization 
of actin filaments, which results in the weakened adhesion of the host cell to the 
extracellular matrix [56]. And finally, the injected phosphoinositide phosphatase IpgD 
uncouples the plasma membrane from the actin cytoskeleton thereby facilitating the 
remodeling of membranes and actin [57]. 
1.5 Phagosome escape, replication and intra - and intercellular 
dissemination 
Within less than 15 minutes S. flexneri lysis the macropinocytic vacuole and escapes 
into the host cell cytosol [58]. Membrane lysis is mediated by the T3SS translocator 
proteins IpaB, IpaC and IpaD [59-61]. Furthermore, IpaH7.8 has been shown to be 
involved in phagosome escape in macrophages by a yet unknown mechanism [62]. 
Liberated S. flexneri bacteria start to replicate in the host cell cytosol, protected from 
immune system components present in the extracellular environment. In order to evade 
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from the intracellular host defense S. flexneri follows two strategies: (I) spreading from 
cell to cell and (II) the manipulation of host cell immune signaling, which is described in 
section 2.3. 
S. flexneri exploits the host cell actin assembly machinery to move through the 
cytoplasm and into adjacent epithelial cells. The effector protein IcsA (VirG) is localized 
at one pole of the bacterium and mediates actin polymerization by binding to the host 
protein N-WASP[34, 63, 64]. Emerging actin filaments localized at one pole of the 
bacterium generate propulsive forces and allows S. flexneri to propel through the 
cytoplasm of the host cell. The movement of the bacterium through the cell is supported 
by the action of the T3SS substrate VirA, which degrades α-tubulin to weaken the 
intracellular microtubule network [65]. In addition, intracellular replication and motility of 
the bacteria depends on the ability of S. flexneri to escape from the host’s autophagy 
machinery. Autophagy is a crucial process for survival of cells and mediates the 
degradation of undesirable cellular components including invasive microbes in double-
membrane compartments. The effector protein IcsB protects S. flexneri from autophagy 
recognition [66, 67]. By binding to IcsA, IcsB masks the autophagy-inducing-recognition 
site of IcsA, and thus the bacteria cannot be engulfed by autophagic vacuoles and are 
therefore protected from degradation. When moving bacteria contact the host cell 
membrane, membrane protrusions into the adjacent cell are formed, which are actively 
endocytosed by the neighboring cell in a myosin light chain kinase and cadherin 
dependent process [68, 69]. Inside, the new host cell S. flexneri starts a new replication 
cycle after having lysed the vacuole. 
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2 Innate Immunity 
Vertebrates are constantly exposed to microorganisms or toxic substances through 
contact, ingestion and inhalation. The immune system evolved to protect multicellular 
organisms from environmental stresses. The evolutionary older innate immune system 
comprises the first line of defense against invasive pathogens in a rapid but non-
specific manner. There are several strategies how this is achieved, including formation 
of physical barriers at epithelial surfaces, complement activation, induction of an 
inflammatory response, removal of pathogens by PMNs and macrophages and finally 
the activation of the adaptive immune system, which elicits a specific response to the 
invading pathogen and provides immune memory. 
2.1 Innate immune receptors: sensors of invading microbes 
Fast pathogen recognition and the initiation of an inflammatory response are crucial for 
the successful elimination of invading pathogens. This is achieved by germ line 
encoded pattern recognition receptors (PPRs), which are expressed by hematopoietic 
cells of myeloid origin including dendritic cells, macrophages and neutrophils as well as 
non-hematopoietic cells such as epithelial cells. PRRs detect conserved components 
expressed uniquely by microbes, so called pathogen-associated molecular patterns 
(PAMPs), e.g. lipopolysaccharide (LPS), lipoproteins or muramylpeptides (MDPs) [70]. 
There is emerging evidence that these receptors are also able to recognize 
endogenous molecules originating from injured or dying cells, termed damage 
associated molecular patterns (DAMPs), e.g. ATP or DNA [71]. Up to now, four different 
families of PRRs have been identified. Members of the Toll-like receptors (TLRs) family 
and the C-type lectin receptor (CLR) family are transmembrane proteins. Receptors 
belonging to these two families are located at plasma and endosomal membranes to 
survey the extracellular compartment and the endosomes for the presence of PAMPs 
and DAMPs. Members of the Retinoic acid-inducible gene (RIG)-I-like receptor (RLR) 
family and NOD-like receptor (NLR) family are cytoplasmic receptors [70]. These 
receptors sense the presence of intracellular PAMPs and DAMPs. Invading bacteria are 
recognized by TLRs and NLRs, whereas RLRs detect nucleic acids from viruses and 
CLRs sense fungal PAMPs [70] (Figure I.2). Upon activation of these receptors, various 
signaling cascades are triggered that control transcription factors such as NF-κB, AP-1, 
Elk-1, ATF2 and members of the interferon regulatory factor (IRF) family [72-74]. 
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Activation of these transcription factors in turn leads to the expression of 
proinflammatory genes such as chemokines including IL-8 and CCL2 that attract other 
immune cells to the site of infection, as well as cytokines such as IL-1β, IL-6 and TNFα 
that modulate the immune response. 
 
 
Figure I.2 PRRs recognize PAMPs derived from different classes of pathogens. Viruses, 
bacteria, fungi, and protozoa expose various PAMPs, some of which are shared between 
different classes of pathogens. Main PAMPs are nucleic acids, including DNA, dsRNA and 
ssRNA, as well as surface glycoproteins (GP), lipoproteins (LP), and membrane components 
such as peptidoglycan (PG), lipoteichoic acid (LTA), lipopolysaccharide (LPS), and GPI anchors. 
These diverse PAMPs are recognized by different families of PRRs including TLRs (Toll-like 
recpetors), RLRs (RIG-I-like receptors), NLRs (NOD-like receptors) and DNA sensors. Adapted 
with modifications from [75] 
2.1.1 Toll like receptors 
Members of the TLR family are the most extensively studied class of PRRs. To date 13 
mammalian TLRs have been identified [76]. They are integral membrane proteins that 
expose leucin-rich-repeat (LRR) domains to an extracellular or luminal compartment 
and a cytoplasmic Toll/interleukin-1 (IL-1) receptor homology (TIR) domain into the 
cytosol. The LRR domain is responsible for molecular recognition, whereas the TIR 
domain transduces signals to intracellular adaptor proteins leading to the activation of 
downstream signaling pathways that control an effective immune response to invading 
organisms [77]. TLRs interact with a variety of PAMPs derived from bacteria, viruses, 
fungi and parasites (Table I.3) and DAMPs derived from injured cells (Table I.4). 
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Table I.3 PAMPs recognized by TLRs, NLRs and other PRRs. 
Species PAMP TLRs NLRs, other PRRs 
Bacteria LPS TLR4  
Lipoproteins, PDG, LTA, 
Lipoarabinomannan  
TLR2/1, TLR2/6 NOD1, NLRP3, NLRP1 
MDP  NOD2, NLRP1 
Flagellin TLR5 NLRC4 
DNA TLR9 AIM2 
RNA TLR7/TLR13 NLRP3 
Viruses DNA TLR9 AIM2, DAI, IFI16 
RNA TLR3, -7, -8 RIG-I, MDA5, NLRP3 
Structural protein TLR2, -4  
Fungi Zymosan TLR2, -6 Dectin-1 
β-glucan TLR2, -6 Dectin-1, NLRP3 
Mannan TLR2, -4  
DNA TLR9  
RNA TLR7  
Parasites tGPI-mutin (Trypanosoma) TLR2  
Glycoinositolphospholipids 
(Trypanosoma) 
TLR4  
DNA TLR9  
Hemozoin (Plasmodium) TLR9 NLRP3 
Profilin-like molecule 
(Trypanosoma gondii) 
TLR11  
Adapted from [76, 78, 79] and NLR nomenclature according to nomenclature standards defined 
by [80] 
Table I.4 DAMPs sensed by PRRs. 
DAMP Putative sensor 
HMGB1 TLR2, TLR4, TLR9, RAGE and CD24 
HSPs TLR2, TLR4, CD91, CD24, CD14 and CD40 
S100 proteins RAGE 
SAP130 CLEC4E 
RNA TLR3 
DNA TLR9 and AIM2 
Uric acid and MSU crystals NLRP3 
ATP NLRP3 
Hyaluronan TLR2, TLR4 and CD44 
Biglycan TLR2 and TLR4 
Versican TLR2 
Heparan sulphate TLR4 
Formyl peptides (mitochondrial) FPR1 
DNA (mitochondrial) TLR9 
CPPD crystals NLRP3 
β-amyloid NLRP3, CD36 and RAGE 
Cholesterol crystals NLRP3 and CD36 
IL-1α IL-1R 
IL-33 ST2 
Adapted with modifications from [71] 
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TLR1, -2, -4, -5, -6, and 11 are localized at the cell surface where they mainly recognize 
extracellular cell wall products that are unique to microbes. Other TLRs, such as TLR3, 
-7, -8, -9 and -13, are located at intracellular vesicles such as endosomal or lysosomal 
membranes detecting nucleic acids derived from viruses or bacteria being degraded in 
the lysosom. Discrimination between self and non self is achieved rather by the 
localization of the ligands in endosomal compartments than by a specific sequence, 
modification or species origin [81, 82]. 
Following ligand binding, TLRs undergo homo- or heterodimerization. Depending on the 
individual stimulus and the corresponding TLR, different TIR domain containing adaptor 
proteins are recruited to the receptor complex. To date, five adaptor proteins are known 
including myeloid differentiation factor 88 (MYD88), MYD88-adaptor like (MAL), TIR 
domain containing adaptor inducing IFN-β (TRIF), TRIF-related adaptor molecule 
(TRAM), and sterile alpha and HEAT-Armadillo motifs (SARM) [83]. According to the 
adaptor molecules that are engaged to the TLRs, two major intracellular signaling 
pathways can be activated. One is referred to as the MYD88 dependent pathway, which 
is activated by all TLRs, except TLR3, and is mediated via IRAK-1 and IRAK-4, TNF 
receptor-associated factor 6 (TRAF-6), and results in MAP kinase activation and the 
activation of the IkB kinase (IKK) complex. Subsequently, the transcription factors AP-1 
and NF-κB are activated, which control the expression of proinflammatory genes. The 
second pathway, known as TRIF pathway, gets activated downstream of TLR3 or 
TLR4, when recruited to endosomal membranes, and leads to the activation of the 
interferon regulated factors (IRF) family of transcription factors resulting in the synthesis 
of interferon (IFN) [77] (Figure I.3). 
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Figure I.3 Mammalian TLR downstream signaling. TLR5, TLR11, TLR4, and the 
heterodimers of TLR2/TLR1 or TLR2/TLR6 are localized at the cell surface to sense 
extracellular microbial components. TLR3, TLR7/TLR8, TLR9 and TLR13 localize to the 
endosomes, where they detect nucleic acids. TLR4 localizes at both, the plasma membrane 
and the endosomes. Ligand-binding induces the dimerization of the receptors and allows the 
recruitment of the adaptor proteins including MYD88, MAL, TRIF, or TRAM via homotypic 
interaction of the TIR domains. Receptor binding of the adaptor proteins stimulates downstream 
signaling pathways that are mediated by IRAK proteins and TRAF proteins leading to the 
activation of the MAP kinases JNK and p38, and to the activation of transcription factors 
including NF-κB, IRF3, IRF7, AP-1 and CREB. Activation of the TLR signaling pathway leads to 
the expression of proinflammatory cytokines, and in the case of the endosomal TLRs to the 
expression of type I interferon (IFN). CREB, cyclic AMP-responsive element-binding protein; 
IRAKs, IL-1R-associated kinases; JNK, JUN N-terminal kinase; MAL, MYD88-adaptor-like 
protein; MAPKs, mitogen-activated protein kinases; MYD88, myeloid differentiation primary-
response protein 88; dsRNA, double-stranded RNA; IKK, inhibitor of NF-κB kinase; LPS, 
lipopolysaccharide; MKK, MAP kinase kinase; RIP1, receptor-interacting protein 1; rRNA, 
ribosomal RNA; ssRNA, single-stranded RNA; TAB, TAK1-binding protein; TAK,1 TGFβ-
activated kinase 1; TBK1, TANK-binding kinase 1; TRAF, TNF receptor-associated factor; 
TRAM, TRIF-related adaptor molecule; TRIF, TIR domain-containing adaptor protein inducing 
IFN-β. Adapted from [76] 
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2.1.2 NOD like receptors 
The human NOD-like receptor (NLR) family consists of 22 members that are 
characterized by a modular domain organization (Figure I.4). They are composed of a 
C-terminal leucine-rich repeat (LRR) domain involved in ligand sensing, a central 
nucleotide-binding and oligomerization (NBD) domain required for nucleotide binding 
and self-oligomerization and finally a N-terminal protein-protein binding domain, that 
interacts with downstream adaptor proteins. Based on the N-terminal effector domain, 
NLRs are classified into subfamilies: NLRA, NLR containing an acidic domain (CIITA), 
NLRB, NLR with baculovirus inhibitor of apoptosis repeat (BIR) domains (NAIP), NLRC 
consisting of NLRs with a caspase activation and recruitment (CARD) domain (NOD1, 
NOD2, NLRC3, NLRC4/IPAF, NLRC5), NLRP, NLR with a pyrin domain (PYD) (NLRP1 
to NLRP14) and finally, NLRX, NLR with no strong homology to the N-terminal domain 
of any other NLR subfamily member [80]. NLRs are intracellular sensors of PAMPs and 
DAMPs. Upon activation of NLRs, diverse signaling cascades are triggered. Some 
NLRs control the inflammasome-dependent activation of caspase-1 that processes IL-
1β and IL-18 [84] and induce caspase-1 dependent pyroptotic cell death [85]. Another 
set of NLRs activate the NF-κB and MAP kinase signaling pathways and thereby induce 
the transcription of proinflammatory genes [86]. Some NLR receptors trigger autophagy 
[87] and some induce type I interferon signaling [88]. 
2.1.2.1   Non-inflammasome NLRs: NOD1 and NOD2 
NOD1 and NOD2 are the first characterized and best studied members of the NLRC 
subfamily of NLRs. NOD1 and NOD2 harbor besides their LRR and NBD domain one or 
two caspase recruitment domains (CARD), respectively. They are intracellular sensors 
for fragments of the bacterial cell wall component PDG, representing a PAMP. NOD1 
detects γ-D-glutamyl-meso-diaminopimelic acid (iE-DAP), which is found primarily in the 
PDG of gram-negative bacteria, but also in certain gram-positive bacteria such as 
Listeria spp. and Bacillus spp. [89, 90]. Nevertheless, NOD1 is seen as sensor for 
gram-negative bacteria. In contrast, NOD2 detects intracellular muramyl 
dipeptide(MDP), which is ubiquitously present in bacteria and therefore NOD2 is 
referred to as a general sensor of bacteria [91]. NOD1 is expressed ubiquitously in 
antigen-presenting cells (APCs) including macrophages and dendritic cells and in 
epithelial cells, whereas NOD2 is mainly expressed in APCs [92]. Furthermore, NOD2 
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Figure I.4 Domain organization of the Nod-like receptor (NLR) family proteins. The overall 
structure of NLRs is a C-terminal leucine-rich repeat (LRR) domain, a central nucleotide binding 
domain (NBD) consisting of a NACHT and NAD domain and a variable N-terminal effector 
domain. The 22 NLR family members are grouped into subfamilies according to their N-terminal 
effector domain. NLRC members contain a CARD domain, NLRP members a PYD domain, 
NLRA members an AD domain, NLRB members BIR domains and finally, NLRX members 
possess an undefined N-terminal domain. AD, acid transactivation domain; BIR, baculoviral 
inhibitory repeat; CARD, caspase recruitment domain; FIIND, function-to-find domain; NAD, 
NACHT-associated domain; NAIP, neuronal apoptosis inhibitor protein; PYD, pyrin domain; X, 
undefined domain. Adapted with modifications from [93] 
 
has been reported to be present in intestinal epithelial cells [94], where its expression 
can be modulated by diverse stimuli [95, 96]. NOD1/2 recognize intracellular iE-DAP or 
MDP, respectively, originating from replicating bacteria. It is estimated that dividing 
gram-negative bacteria recycle only 30-60% of the cleaved PDG during their replication 
cycle, implying that a substantial amount of PDG is released during bacterial replication 
[97]. But NOD proteins are not only sensors for intracellular bacteria. Some extracellular 
bacteria deliver PDG moieties to the cytoplasm of host cells. For instance, Helicobacter 
pylori uses a T4SS for the delivery of PDG to the host cytosol and thereby triggers 
NOD1 signaling [98]. Staphylococcus aureus inserts pore-forming toxins into the cell 
membrane of targeted cells and thereby delivers PDG to the host cytosol to induce 
NOD2 [99]. Furthermore, NOD1/2 ligands can be endocytosed [100, 101] or be 
Introduction 
19 
internalized by oligopeptide transporters, e.g. pH-sensing regulatory factor of peptide 
transporter (PEPT1) [101]. 
Recently, it has been shown, for NOD1 [102] and for NOD2 [103, 104], that both 
receptors directly bind to their cognate ligands. Upon ligand sensing, NOD1 and NOD2 
undergo conformational changes that allow self-oligomerization and the subsequent 
recruitment of the serine/threonine kinase RIPK2 via CARD-CARD protein interactions 
[105]. Receptor bound RIPK2 gets conjugated with lysine 63 (K63)-linked polyubiquitin 
chains. Ubiquitination is a three step process in which an ubiquitin activating enzyme 
(E1) loads an ubiquitin moiety on an ubiquitin-conjugating enzyme (E2) that together 
with an ubiquitin ligase (E3) transfers ubiquitin molecules onto a target protein (Figure 
I.5). Variations in the linkage of the linear polyubiquitin chains determine the fate of 
target proteins. K48-linked polyubiquitin chains mark a protein for degradation by the 
proteasome, whereas K63-linked polyubiquitin chains stabilize signaling complexes by 
providing signaling platforms. Various E3 ubiquitin ligases have been suggested to be 
involved in mediating NOD1 and NOD2 activation to NF-κB including XIAP, TRAF2, 
TRAF5, TRAF6, cIAP1 and cIAP2 [106-110]. Polyubiquitinated RIPK2 allows the se- 
 
 
Figure I.5 The Ubiquitination system. Ubiquitination is a post translational modification and 
involves the covalent attachment of an ubiquitin (Ub) molecule or Ub-chains to target proteins in 
a three step process. First an Ub-activating enzyme (E1) loads an Ub protein, second this Ub is 
transferred from E1 to an Ub-conjugating enzyme (E2) and third, an Ub-ligase (E3) associates 
with the Ub-loaded E2 enzyme and the substrate and attaches the Ub-molecule to the substrate. 
In this process single Ub molecules or various Ub chains are attached to the substrate. Ubiquitin 
polymers are built by linking one of the seven lysin residues of one Ub with the C-terminal glycin 
of the following Ub. The type of linkeage determines the fate of the substrate protein. Adapted 
from [111] 
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quential association and activation of the TAK1-TAB1-TAB2 and IKKα-IKKβ-
NEMO/IKKγ complexes. Activated IKK phosphorylates the NF-κB inhibitor-α (IκBα) 
thereby marking it for K48-linked ubiquitination and subsequent proteasomal 
degradation. Liberated NF-κB dimers translocate to the nucleus and induce 
transcription of target genes [112]. TAK1 belongs to the family of MAP3 kinases and, as 
such, activates, besides the IKK protein complex, the MAP kinases p38 and JNK [112, 
113]. JNK controls the activation of the transcription factor AP-1 [114], whereas p38 
mediates histone H3 phosphorylation, thereby making DNA accessible for the activated 
transcription factors [115]. The activation of the NF-κB and the MAPK signaling 
pathways downstream of NOD1 and NOD2 receptors results in the expression of 
proinflammatory cytokines, such as TNF-α and IL-6, chemokines including, IL-8, 
CXCL1, CXCL2 and CCL2, and antimicrobial peptides, including defensins [105, 116-
118] (Figure I.6). 
 
 
 
Figure I.6 NOD1/2 signaling 
pathway. Upon ligand 
binding NOD1/2 recruits 
RIPK2 and various E3 ligases 
to the receptor complex. K63 
Ub-chains are attached to 
RIPK2 leading to the 
recruitment and the activation 
of the TAK1 and IKK 
complexes. IKK 
posphorylates IκBα, and 
thereby marks it for K48-
linked polyubiquitination and 
subsequent degradation by 
the proteasome. NF-κB 
(p50/p65) is no longer 
sequestered in the cytosol 
and translocates to the 
nucleus to induce gene 
expression. TAK1 also 
activates MAP kinases which 
in turn activate AP-1 another 
transcription factor that 
contributes to the expression 
of proinflammatory genes. 
Adapted with modifications 
from [111] 
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In addition to activation by cognate ligands, NOD1 and NOD2 can be activated 
independent of ligand binding. NOD1 has been shown to sense cytosolic microbes by 
sensing the activation state of small Rho GTPases in an in vitro Salmonella enterica 
serovar Typhimurium infection model. The Salmonella effector protein SopE, harboring 
GEF activity, induces membrane ruffle formation by activating RAC1 and CDC42. 
NOD1 was shown to be recruited to the activated RHO GTPases and triggered NF-κB 
activation in a RIPK2-dependent manner. Furthermore, ectopic expression of 
constitutively active RHOA, RAC1 and CDC42, was sufficient to activate the NOD1 
signaling pathway [119]. Moreover, it has been shown that ARHGEF2 (also known as 
GEF-H1), which triggers RHOA activation, potentiates NOD1 and NOD2 signaling 
independent of ligand binding [120, 121]. 
There are other pathways that are triggered by NOD1 and NOD2. One is autophagy 
that is an important cellular mechanism to remove invading microbes. Recent research 
has unraveled that NOD1 and NOD2 recruit the autophagy protein ATG16L1 to the 
entry site of bacteria, mediating the degradation of invading pathogens [87]. NOD1 and 
NOD2 are also involved in the activation of the adaptive immunity and the expression of 
type I INF genes [88, 122, 123]. 
2.1.2.2  The inflammasomes 
Inflammasomes contribute to innate immunity and have been shown in vivo, to 
participate in the antimicrobial immune response [41]. Inflammasomes are multi protein 
complexes that are assembled from NLRs that form platforms for the activation of 
inflammatory caspase-1. Some NLRs including NLRP1 and NLRP3, require the adaptor 
protein ASC for the recruitment of caspase-1, others like NLRC4 directly bind and 
activate caspase-1. Furthermore, NAIP proteins have been shown to associate to 
certain NLRs providing ligand specificity. Caspase-1 activation by inflammasomes 
results in the proteolytic maturation and controlled secretion of proinflammatory 
cytokines such as IL-1β and IL-18 [124-126]. Moreover, activated caspase-1 induces 
pyroptosis, a form of programmed cell death (PCD) frequently observed during 
microbial infections. It combines characteristics of apoptosis, such as nuclear 
condensation and DNA fragmentation, and of necrosis, including pore formation in the 
plasma membrane, followed by cell swelling and osmolytic lysis [127, 128]. Recently, 
caspase-11 was as well associated with inflammasome activation in response to gram-
negative bacteria, leading to pyroptosis and release of cytokines such as IL-1α 
independently of caspase-1 activation [129, 130]. Inflammasome activation requires two 
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signals. The first is a priming signal, which is mediated by TLRs, NLRs, TNF receptors 
or IL-1 receptors and leads to NF-κB activation resulting in the synthesis of the pro-
forms of IL1-β and IL-18 and of NLRs required for inflammasome formation [131, 132]. 
The second signal depends on specific DAMPs and PAMPs that induce inflammasome 
formation and promote caspase-1 or caspase-11 activation followed by cytokine 
secretion and pyroptosis. 
There are several inflammasomes described so far of which the NLRP3 (also known as 
NALP3) and the NLRC4 (also known as IPAF) inflammasomes are the best studied. 
NLRP3 and NLRC4 are mainly expressed in myeloid cells. NLRP3 is activated in 
response to bacteria, viruses and fungi by multiple stimuli, including PAMPs, DAMPs 
and toxins [84] (Tables I.3 and I.4), whereas NLRC4 senses several pathogenic gram-
negative bacteria that are equipped with a T3SS or a T4SS including Salmonella 
enterica ser. Typhimurium, Shigella flexneri, Legionella pneumophila, and 
Pseudomonas aeruginosa [84] which deliver flagellin or rod components of the T3SS 
(PrgJ, Mxil) to the host cell cytosol [29, 133]. 
2.2 Role of the intestinal mucosa in innate immunity 
The intestine forms the biggest surface in the body in contact with the environment. 
Besides functioning in the uptake of nutrients, it has to ensure tolerance to commensal 
bacteria and, at the same time, protect the body against invasion of pathogenic 
microorganisms. A single layer of epithelial cells forms a physical and a biochemical 
barrier that separates the body from the intestinal microbiota and from pathogenic 
microorganisms. The intestinal epithelium consists of a majority of intestinal epithelial 
cells (IEC), which are connected by tight junctions and form an impermeable barrier 
between the body and the luminal contents. IEC have a dual function. They are 
responsible for the uptake of nutrients and they are part of the innate immune system. 
Their immune functions are to produce antimicrobial peptides that are secreted into the 
lumen and to act as sentinels of the immune system that recognize invading pathogens 
and induce an immune response. Besides IECs, the epithelium includes specialized 
cells. One kind are M-cells, that are localized above the Peyer’s patches or above 
isolated lymphoid follicles. M-cells sample luminal antigens directly to the submucosal 
space and present these microbiota-derived antigens to macrophages and dendritic 
cells. Finally there are the goblet cells, which secrete the protective mucus layer and 
Paneth cells that reside in the crypts of the small intestine but not of the colon and 
secrete high amounts of antimicrobial peptides. 
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2.2.1 Expression and localization of PRRs at the intestinal epithelium  
The mucosa of the large intestine is constantly exposed to the commensal microbiota. 
Even though the commensal bacteria are separated from IECs by a thick mucus layer, 
large amounts of surface components including LPS, PDG or flagellin from replicating 
bacteria are released. Therefore the difficulty of PRR function at the intestinal 
epithelium is to discriminate between pathogenic microorgansims and the commensal 
microbiota. Tolerance to commensal bacteria can be achieved by the expression 
pattern and the localization of PRRs. For example, some of the surface exposed TLRs 
are expressed and localized exclusively in the crypt epithelial cells [134, 135] and thus 
far away from the gut flora. TLR4 sensing of LPS is not possible because the essential 
co-receptor MD-2 is poorly expressed in IECs [134]. In addition, TLR4 is sequestered in 
the golgi and has been found to respond to internalized LPS [136, 137]. TLR5, the 
sensor for bacterial flagellin, is expressed only in the colon at the basolateral side of 
IECs [138]. Another strategy for tolerance to commensal bacteria is represented by the 
NLRs that are cytosolic PRRs. In IECs, NOD1 and NOD2 are expressed and provide 
the first line of defense against pathogens that avoid immune recognition by TLRs [94, 
139]. 
2.3 S. flexneri infection of epithelial cells: recognition and 
manipulation of host signaling 
Upon invasion into epithelial cells, S. flexneri is recognized by NOD1 [35]. NOD1 is 
recruited to phagosomal membrane remnants produced after the bacteria escape from 
the vacuole to reach their main replicative niche, the cytosol of IECs. NOD1 activation 
leads to RIPK2 and TAK1 mediated activation of the NF-κB and MAP kinase pathways 
as described in section ‘Noninflammasome NLRs: NOD1 and NOD2’. Only recently, it 
became evident that the vacuolar membrane remnants produced by S. flexneri are 
recognized as DAMPs and activate NF-κB and the MAP kinases. At bacterial entry sites 
diacylgylcerol (DAG) accumulation in host membranes was observed and subsequent 
activation of a protein complex consisting of CARD-BCL10-MALT1 (CBM), followed by 
TRAF6 and TAK1 activation resulting in the activation of NF-kB and the MAP kinases 
[140]. It is assumed that PKC mediates DAG dependent assembly of the CBM complex. 
S. flexneri by delivering many different effector proteins via the T3SS into IECs, 
effectively counteracts host signaling and dampens inflammation by targeting the NF-κB 
and the MAP kinase pathways [141, 142] (Figure I.7). The effector protein IpaH9.8  
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Figure I.7 Manipulation of host signaling by S. flexneri. Shigella effector proteins injected via 
the T3SS into the host cell cytosol interfere with host signaling pathways and dampen 
inflammation. PDG released from replicating Shigella triggers the NOD1 signaling pathway, 
whereas vacuolar membrane remnants act as DAMPs and induce the TRAF6-TAK1 pathway. 
Both pathways together activate NF-κB and the MAPKs that control the expression of 
proinflammatory genes. The injected bacterial effector proteins interfere with host signaling 
proteins and suppress inflammation. For more details refer to the text. Adapted with 
modifications from PhD Thesis from C. Schmutz and [141]. 
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having E3 ligase activity, when secreted into host cells acts in the cytoplasm and in the 
nucleus of target cells. Cytoplasmic IpaH9.8 targets the NF-κB pathway by 
polyubiquitinating the regulatory IKKγ subunit of the IKK protein complex, resulting in its 
degradation and thereby NF-κB remains sequestered in the cytosol [143]. In the 
nucleus, IpaH9.8 inhibits the mRNA splicing factor U2AF, which again results in a 
reduced inflammatory response [144]. Recently, another IpaH E3 ubiquitin ligase family 
protein, IpaH0722, was shown to inhibit the PKC mediated activation of NF-κB. 
IpaH0722 was found to polyubiquinate TRAF2, a protein downstream of PKC, and 
thereby marking it for proteasomal degradation [145]. The serine/threonine kinase 
OspG inhibits NF-κB activation by binding to the E2 ubiquitin conjugating enzyme 
UbcH5b, thereby preventing the polyubiquitination of phospho-IkB and its subsequent 
degradation [146]. Consequently, NF-κB is sequestered in the cytoplasm and target 
genes are not expressed. Furthermore, the effector protein OspZ has been reported to 
inhibit NF-κB activation in TNFα or IL-1 stimulated cells ectopically expressing OspZ 
[147]. The precise mechanism remains elusive. The MAP kinases p38 and ERK are 
targeted by the effector protein OspF. OspF is a phosphothreonine lyase that 
translocates to the nucleus and irreversibly dephosphorylates the MAP kinases p38 and 
ERK. The role of OspB is controversial. One group reported that OspB potentiated 
NOD1 dependent signaling to NF-κB in an ARHGEF2 (GEF-H1) dependent manner 
[120], whereas in another study, OspB was found to dampen inflammation by 
interacting with the retinoblastoma protein [148]. Recently, it was reported, that the 
effector protein OspI, a glutamine deamidase, interferes with the DAMP induced NOD1 
independent-TRAF6-NF-κB signaling pathway. OspI selectively deamidates UBC13, an 
E2 ubiquitin conjugating enzyme, that is required to activate the E3 ubiquitin ligase 
TRAF6. As a consequence TRAF6 mediated NF-κB activation is impaired in response 
to S. flexneri infection. [140]. 
Finally, it has been shown that during Shigella infection the expression of anti-microbial 
peptides (AMP), including LL-37 and β-defensin, is reduced in human rectal epithelium 
of patients [23]. How Shigella dampens the production of AMPs remains currently 
unknown. Some data indicate that the Shigella transcription factor MxiE could be 
responsible for the suppressing effect suggesting that effector proteins could be 
involved [149]. However, during Shigella infection massive amounts of the cytokine IL-8 
are produced [38]. IL-8 is a potent chemoattractant for PMNs, which migrate from the 
periphery to the site of infection. At early stages of Shigella infection, the invasion of 
PMNs destabilizes the integrity of the intestinal epithelium and thereby favors Shigella 
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invasion. But at later stages of infection, they mediate the clearance of infection [150, 
151]. In section 3.3, the host mechanism that allows counteracting the immune 
suppressive activity of bacterial effector proteins is presented. 
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3 Cellular communication 
Multicellular organisms use cell-cell communication to coordinate their behavior to the 
benefit of the entire organism. The communication mechanisms depend on signaling 
molecules that are produced to communicate with neighboring cells but also to signal to 
distant tissues. Signaling molecules, including small peptides, amino acids, nucleotides 
or nitric oxide, are sensed by receptors that are located at cell membranes or in the 
cytosol of cells. Upon binding of their cognate ligands, they engage a variety of 
intracellular signaling proteins that direct the signal to the appropriate parts of the cell. 
Intracellular signaling proteins are scaffolding proteins, kinases, phosphatases, GTP-
binding proteins, ubiquitin ligases and many more. At the end of signaling cascades are 
target proteins, which are altered after activation of the pathway, and allow the cell to 
change its behavior in response to environmental changes. Depending on the target 
protein, different cellular processes are affected including metabolic queues, gene 
expression, cell shape or movement. 
3.1 Principles of cellular communication 
There are different mechanisms that allow cell-cell communication. Some allow 
communication over long distances such as endocrine and synaptic signaling, whereas 
other mechanisms such as juxtacrine (also known as contact dependent), autocrine and 
paracrine signaling allow communication over short distances to coordinate localized 
responses. Such communication over short distances is important during the initial 
stages of immune responses. When a signaling molecule is secreted and diffuses over 
a short distance to act on neighboring cells, this is called paracrine signaling. If such a 
secreted molecule binds to receptors on the cell that produced the signaling molecule, 
this is called autocrine signaling. A prerequisite for juxtacrine signaling is direct contact 
between cells or cells and the extracellular matrix. There exist three types of juxtacrine 
signaling: (I) A signal protein bound to the surface of the signaling cell binds to a cell 
membrane receptor of an adjacent cell; (II) communication via gap junctions that 
connect adjacent cells and allow diffusion of small signaling molecules from the 
signaling cell to neighboring cells and (III) interaction of extracellular matrix 
glycoproteins that interact with a cell membrane receptor. 
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3.2 Gap junction mediated cell-cell communication 
Gap junctions are channels that connect the cytoplasm of adjacent cells. The channels 
allow the direct exchange of small (< 1–2 kDa in molecular weight), hydrophilic 
molecules, such as metabolites (e.g. ATP), nutrients (e.g. glucose), and second 
messengers (e.g. cAMP, IP3 and Ca
2+) between cells, which is called gap junctional 
intercellular communication (GJIC) [152]. Gap junctions are formed by two 
hemichannels or connexons, one contributed by each of the communicating cells 
(Figure I.8). Each connexon is assembled by six connexin (CX) proteins. There exist 21 
connexin proteins in humans. They share a common architecture consisting of four 
membrane-spanning domains, two extracellular loops and the cytosolic N-terminal and 
C-terminal part and one cytosolic loop [153]. The cytosolic domains allow the interaction 
with connexin interacting proteins that regulate the assembly, function and degradation 
of gap junctions [154]. There exist many connexin interacting proteins including 
cytoskeletal proteins (microtubules, actin or actin-binding proteins), adherence 
junctional proteins (cadherins), tight junctional proteins (ZO-1, ZO-2) and enzymes 
(kinases and phosphatases). Connexin proteins are expressed in a cell- and tissue 
specific manner. The most abundant connexin in humans is CX43. Most cells 
communicate via gap junctions with a few exceptions such as skeletal muscle cells, 
erythrocytes and circulating lymphocytes [155]. 
 
Figure I.8 Architecture of gap junctions. Gap junctions are clusters of transmembrane 
channels that form gap junction plaques. Two connexons, or hemichannels, in the opposed 
membranes of neighboring cells form a channel for ions and small molecules (< 1-2kDa). Each 
connexon is composed of six connexin subunits. Hemichannels can be either homomeric or 
heteromeric, and gap junctions can be either homotypic or heterotypic based on the composition 
of constituent connexons. Adapted from [156]. 
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As gap junctions allow the intercellular exchange of metabolites and signaling 
molecules, they control various cellular processes, such as maintenance of tissue 
homeostasis, gene expression, induction of apoptosis, growth control and allow the 
coordinated behavior of a group of cells [157, 158]. A proposed mechanism of how 
various cell types communicate with each other to coordinate and synchronize their 
activity are intercellular calcium waves (ICWs), i.e. propagation of increases in 
intracellular calcium concentration through adjacent cells [158]. ICWs have been 
observed in many different cell types including neurons, hepatocytes, smooth muscle 
cells and epithelial cells and are associated with various physiological processes for 
instance, the coordination of airway epithelial ciliary activity or pathological processes 
such as brain ischemia. The current hypothesis for the communication of ICWs is, that 
a local stimulus leads to IP3 production in the challenged cell. IP3 binds to the IP3 
receptor at the endoplasmatic reticulum (ER) and induces an intracellular calcium wave. 
Moreover, IP3 diffuses via gap junctions to neighboring cells, binds to the IP3 receptor 
and initiates consecutive intracellular calcium waves in the bystander cells. In addition, 
or alternatively, the stimulated cell releases ATP via hemichannels or vesicular release, 
which diffuses to adjacent cells, activates P2 receptors (GPCRs), which in turn, 
stimulate IP3 production to induce a calcium wave in the adjacent cell. Propagation may 
involve the regenerative release of ATP. Each mechanism can occur in isolation or 
synergistically (Figure I.9). 
 
 
Figure I.9 Model of intercellular calcium waves. For details refer to text. Adapted from [158] 
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GJIC has also been linked to stress responses, where a single cell exposed to a stress 
induces a biological response in the adjacent healthy tissue. For instance, single 
irradiated cells secrete cytokines and propagate signals via gap junctions to trigger 
DNA damage in non-irradiated bystander cells [159]. Recently, we have shown that 
during bacterial infection of epithelial cells, GJIC mediates the propagation and 
amplification of proinflammatory signals from infected to uninfected bystander cells [39], 
which is described in more detail in the following section. Antiviral immune responses 
have as well been reported to be dependent on cell-cell communication mediated by 
gap junctions [160, 161]. One group observed that single cells stimulated with double-
stranded (ds) DNA, induced interferon-β and TNFα expression in bystander cells [161]. 
Recently, Ablasser and colleagues discovered a mechanism for bystander activation in 
response to cytosolic DNA. DNA is sensed by a receptor called cyclic GMP-AMP 
(cGAMP) synthase (cGAS). Stimulated cGAS catalysis the production of the second 
messenger cGAMP, which binds to a receptor located at the ER called STING. STING 
activation results in the induction of an antiviral immune response, including the 
secretion of type I IFNs. cGAMP produced in dsDNA stimulated cells, was found to be 
delivered to bystander cells in a gap junction dependent manner and resulted in a 
STING mediated antiviral immune response [160]. 
3.3 Cell-cell propagation of proinflammatory signals during 
bacterial infection 
By the use of secreted effector proteins, S. flexneri effectively elicits immune 
suppressive activity. Even though, in the rabbit-ligated ileal loop model of S. flexneri 
infection, as well as in rectal biopsies of Shigella infected patients, massive secretion of 
proinflammatory cytokines is observed [38, 162]. In a recent study, we described a 
mechanism of communication between infected and uninfected epithelial cells that 
potentiates innate immunity during infection by the enteroinvasive bacterium S. flexneri 
[39] (see V Appendix). We showed that NF-κB and the MAP kinases p38, JNK and ERK 
are activated in uninfected cells surrounding the sites of infection. The propagation of 
these proinflammatory signals leads to massive secretion of proinflammatory cytokines 
such as IL-8, tumor necrosis factor α (TNFα) and granulocyte-macrophage colony-
stimulating factor (GM-CSF), by uninfected bystander cells. Bystander IL-8 production 
can be triggered by recognition of peptidoglycan and is mediated by gap junction 
communication between consecutive epithelial cells. Finally, bystander IL-8 expression 
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was also observed in response to other pathogens such as S. enterica ser. 
Typhimurium and Listeria monocytogenes. 
In a parallel study, the mechanism of bystander activation induced by L. 
monocytogenes was investigated in a murine intestinal epithelial cell infection model. 
Similar to our findings, bystander activation induced by L. monocytogenes was 
independent of paracrine signaling. In contrast, whereas S. flexneri induced bystander 
activation required functional gap junctions, in the Listeria infection model, bystander 
activation was mediated by reactive oxygen intermediates (ROIs) produced by the 
NADPH oxidase (NOX) 4. Inhibition of ROI production resulted in abolished bystander 
activation and subsequently abolished production of proinflammatory cytokines 
including CXCL2 (also known as MIP-2, the mouse homolog of human IL-8) and 
CXCL5 in bystander cells. [163]. 
Altogether, this indicates that host organisms evolved strategies to counteract bacterial 
manipulation that suppresses the induction of an inflammation response and thereby 
ensure defense. In addition, the mechanism of bystander activation amplifies the 
immune response to invasive bacteria and might give the host an advantage in clearing 
bacterial infection. 
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4 Aim of the Thesis 
While the innate immune response is effectively suppressed by S. flexneri injected 
effector proteins, massive IL-8 secretion is observed during shigellosis [38]. We have 
recently found a novel mechanism of cell-cell communication between infected and 
uninfected neighboring cells that allows an infected host to counteract bacterial 
manipulation and to amplify the immune response [39] (see V Appendix). By monitoring 
of proinflammatory signals at the single cell level during S. flexneri infection, we found 
that NF-κB and MAP kinase activation was propagated from infected to adjacent 
uninfected neighboring cells, which we called bystander cells. Uninfected bystander 
cells were found to be the main source of IL-8 secretion. In addition, we could show that 
signals between infected and bystander cells were mediated via gap junctions. Finally, 
we found by microinjecting the NOD1 ligand TriDAP into epithelial cells that activation 
of the NOD1 signaling pathway was sufficient to induce bystander IL-8 expression, 
suggesting that the recognition of Nod1 ligands in infected cells may be sufficient to 
generate the underlying signals that mediate IL-8 expression in bystander cells of S. 
flexneri infection (Figure I.10).  
In order to dissect the molecular mechanism of cell–cell communication based 
propagation of proinflammatory signals during infection, we followed three strategies: a 
genome wide RNAi screen in HeLa cells (in collaboration with C.A. Kasper) a LC-
HRMS screen for small metabolites and nucleotides (in collaboration with N. Delmotte 
and P. Kiefer from J.A. Vorholts group at the ETHZ) and a hypothesis driven approach. 
We aimed at identifying new candidate proteins that are involved in the process of 
bystander IL-8 expression during Shigella infection. Furthermore, we investigated 
signaling events taking place sequentially in infected and in bystander cells during 
infection. And finally we set out to identify the signaling molecule(s) responsible for the 
propagation of proinflammatory signals from infected to uninfected bystander cells. 
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Figure I.10 Model of bystander activation. Invasive S. flexneri are detected in epithelial cells 
by sensing of PDG by the PRR NOD1. Activated NOD1 oligomerizes and recruits RIPK2 to the 
receptor complex. The subsequent polyubiquitination of RIPK2 allows association of the TAK1 
and IKK protein complexes followed by the activation of NF-κB and MAPKs. Altogether control 
the expression of proinflammatory genes. Secreted bacterial effector proteins inhibit 
inflammatory signals in infected cells and suppress gene expression. Infected cells are able to 
propagate NF-κB and MAP kinase activation to adjacent cells leading to IL-8 secretion in 
bystander cells of infection. Cell-cell communication of proinflammatory signals is mediated via 
gap junctions and leads to massive amplification of the inflammation response. 
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1 Statement of contribution 
I have performed most of the experiments in this chapter by myself. In addition, I did 
most of the quantifications that were based on image analysis. Quantification of mixed 
cell population assays and of U73122 treated HeLa cells were done by C.A. Kasper. I. 
Sorg performed Ca++/iE-DAP costimulation experiments in HeLa cells and the in vitro 
infection assays of BAPTA treated HeLa cells. 
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2 Results 
2.1 NF-κB and TAK1 are essential for IL-8 expression in 
bystander cells of S. flexneri infection 
To unravel the molecular mechanism of bystander Il-8 expression, I addressed the two 
qustions: (I) what kind of signaling events in infected cells trigger bystander IL-8 
expression? And (II) how are NF-κB and the MAP kinases activated in bystander cells? 
S. flexneri infecting epithelial cells are recognized by the PRR NOD1 that oligomerizes 
upon binding of peptidoglycan moieties derived from replicating bacteria [112, 164]. 
Downstream of NOD1 the MAP3 kinase TAK1 gets activated. From TAK1 signals 
diverge; one signaling branch leads to MAP kinase activation, whereas the second 
signaling branch leads to the activation of the transcription factor NF-κB that controls IL-
8 expression. First the important function of NF-κB and TAK1 during S. flexneri infection 
was verified. To do so, I monitored the IL-8 response of HeLa cells depleted for NF-κB 
or TAK1 by means of RNA interference. Cell monolayers were infected at low 
multiplicity of infection (MOI) with S. flexneri ΔvirG the non-motile deletion mutant [165]. 
This mutant was used throughout the study, to avoid infection of bystander cells by 
intercellular bacterial spreading. Newly synthesized IL-8 was trapped in the golgi 
apparatus by treating cells with monensin, a protein transport inhibitor. To visualize IL-8 
accumulation in bystander cells of S. flexneri infected cells, immunofluorescence 
microscopy was performed followed by automated image analysis. As expected, HeLa 
cells depleted for NF-κB (Figure II.1, panel A left) or TAK1 (Figure II.1, panel A right and 
panel B) were not able to induce IL-8 expression in response to S. flexneri infection. In 
addition, I confirmed the TAK1 dependent nuclear translocation of the NF-κB subunit 
p65 by means of immunofluorescence microscopy and automated image analysis as 
described previously [39]. As expected, NF-κB p65 translocation in infected (Figure II.1, 
panel C left) and in bystander cells (Figure II.1, panel C right) during infection of HeLa 
cells depleted for TAK1 was strongly impaired compared to control cells. 
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Figure II.1 
 
A) 
 
 
B) 
 
 
C) 
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Figure II.1 NF-κB and TAK1 are essential for bystander IL-8 production during S. flexneri 
infection. (A) Effect of NF-κB or TAK1 siRNA knock down, on IL-8 production in bystander cells 
of S. flexneri infection. HeLa cells depleted for NF-κB (left) or TAK1 (right) by means of RNA 
interference for 72 hours and infected with S. flexneri (MOI=1). IL-8 staining of monensin treated 
cells after 3.5 hours of infection. Quantification was performed by automated image analysis 
based on the use of threshold intensity values for bacterial and IL-8 detection as described 
previously [39] (see V Appendix) (means ± SD of triplicate wells, graph representative of three 
independent experiments; *p = 6.4E-09; **p = 1.0E-08). (B) Effect of TAK1 depletion on IL-8 
accumulation in bystander cells. TAK1 depleted HeLa cells were infected with S. flexneri. IL-8 
staining of monensin-treated HeLa cells, 3.5 hours post infection (IL-8 in red, S. flexneri in green, 
Hoechst in blue, MOI=0.5). Scale bar, 50 μm. (C) TAK1 dependent NF-κB activation during S. 
flexneri infection. HeLa cells were transfected for 72 hours with TAK1 siRNA, and infected with 
S. flexneri at MOI=1 for 1 hour. The nuclear translocation of NF-κB p65 was monitored by 
immunofluorescence and quantified by automated image analysis. The nuclear/cytoplasmic p65 
intensity ratio was calculated as described previously [39]. The data shown are mean values +/- 
SD of triplicate wells per condition; graph representative of 3 independent experiments; *p = 
3.0E-08;**p = 5.0E-08. (BST = bystander cells) 
 
Next, I investigated firstly whether NF-κB or TAK1 activation was required in S. flexneri 
infected cells for the production of a diffusible signaling molecule responsible for 
bystander activation and secondly whether NF-κB or TAK1 activation was required in 
bystander cells for IL-8 expression. For this purpose, the mixed cell population assay 
was designed, which is described in detail in Figure II.2, panel A and in material and 
methods. Mixed HeLa cell layers consisting of few cells depleted for NF-κB or TAK1, 
respectively, surrounded by a majority of control cells were infected at very low MOI to 
be able to analyze single infection sites. Automated analysis of immunofluorescence 
images was used to quantify the fraction of IL-8 producing control cells at bystander 
position one to five neighboring to either an infected control cell or an infected cell 
depleted for NF-κB or TAK1. It turned out that infected cells depleted for NF-κB (Figure 
II.2, panel B left) or TAK1 (Figure II.2, panel B right) induced the same fraction of IL-8 
positive bystander cells at any given bystander position (red curve) when compared to 
infected control cells (black curve). This data indicates that NF-κB or TAK1 activation in 
infected cells is not required for the production of a diffusible signaling molecule 
responsible for bystander activation. Next, the role of NF-κB or TAK1 for IL-8 
expression in bystander cells was investigated. Mixed cell layers consisting of few 
control cells embedded in a majority of cells depleted for NF-κB or TAK1, respectively, 
were infected at low MOI. Analysis of the propagation of IL-8 expression induced by an 
infected control cell in either control bystander cells or in bystander cells depleted for 
NF-κB or TAK1 revealed, as expected, that NF-κB (Figure II.2, panel C left) and TAK1 
activation (Figure II.2, panel C right) are essential in bystander cells for IL-8 expression. 
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Figure II.2 
 
A) 
 
B) 
 
Figure II.2 NF-κB and TAK1 are required only in bystander cells for IL-8 expression. (A) 
Sketch of mixed cell population assay: At day1, two cell populations were reverse transfected by 
means of small interfering RNA: HeLa cells with a control siRNA (control cells; blue) and HeLa-
GFP cells with specific siRNAs targeting e.g. NF-κB (green). At day 3 (after 48 hours), the two 
cell populations were harvested, mixed at ratios 1 to 5 and 5 to 1 and seeded. At day 4 (after 72 
hours) the mixed cell layers were infected with S. flexneri at MOI=0.02 followed by an 
immunofluorescence staining: Hoechst to visualize cell nuclei, IL-8 was stained with a specific 
antibody and visualized by an Alexa Fluor 647-coupled secondary antibody, bacteria express 
dsRed and knock down cells express GFP. Quantification was performed by automated image 
processing as described previously [39]. (B) Spatial propagation of IL-8 expression triggered 
from either a S. flexneri infected control cell or HeLa-GFP cell depleted for NF-κB (left) or TAK1 
(right) into control bystander cells. Each number corresponds to the fraction of IL-8 producing 
cells for a given bystander cell position. Quantification was performed by automated image 
analysis as described previously [39] (means ± SD of 18 wells, graph representative of 3 
independent experiments; NF-κB: p > 0.18 at any given position; TAK1: p > 0.11 except at 
position 3 (p= 0.02)).  
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C) 
 
D) 
 
Figure II.2 Continued. (C) Spatial propagation of IL-8 production from a S. flexneri infected 
control cell into either control bystander cells or HeLa-GFP bystander cells depleted for NF-κB 
(left) or TAK1 (right). Each number corresponds to the fraction of IL-8 producing cells for a given 
bystander cell position. Quantification was performed by automated image analysis as described 
previously [39] (means ± SD of 18 wells, graph representative of 3 independent experiments; 
NF-κB: p < 2E-04 at any given position; TAK1: p < 2E-06). (D) TAK1 activation in bystander cells 
of S. flexneri infection. Whole cell lysates from HeLa cells untreated or treated with the gap 
junction inhibitor 18β-GA one hour prior to infection, and infected at MOI=4 (lane 3, 4) or at 
MOI=40 (lane 5, 6) with S. flexneri ΔvirG for 45 minutes, were analyzed by immunoblotting using 
a phospho-specific antibody that detects TAK1 phosphorylated at threonine 187 (p-TAK1). Actin 
was used as loading control. (RES = resting cells; INF = infected cells; BST = bystander cells) 
 
As it became evident that TAK1 plays a crucial role in bystander cells to mount a 
proinflammatory response, I aimed at confirming that TAK1 indeed was activated in 
bystander cells during S. flexneri infection. TAK1 activation during S. flexneri infection 
was monitored with a phosphospecific antibody that detects threonine 187 in the 
activation loop of TAK1 [166]. In order to distinguish between signaling events taking 
place in infected and in bystander cells, HeLa cells were either left untreated or treated 
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with the gap junction inhibitor 18β glycyrrethinic acid (18β-GA) prior to infection. In 
absence of treatment, cell layers consisted of around 50% infected cells and 50% 
bystander cells, whereas upon inhibition of gap junctions cell layers consisted of 50% 
infected cells and 50% resting cells. Resting cells did not show any TAK1 
phosphorylation (Figure II.2, panel D, lanes 1 and 2). In contrast, when I infected all 
cells, I observed a strong activation of TAK1, which was not affected by the drug 
treatment, reflecting TAK1 activation induced by invasive S. flexneri (Figure II.2, panel 
D, lanes 5 and 6). In the condition of 50 % infected (and 50 % bystander or resting 
cells, respectively) in absence of drug treatment a strong band was observed 
representing TAK1 activation in infected and in bystander cells (Figure II.2, panel D, 
lane 3), whereas upon treatment with 18β-GA a weak band was observed, representing 
TAK1 activation in infected cells (Figure II.2, panel D, lane 4). These data demonstrate 
that TAK1 is activated in infected and in bystander cells during S. flexneri infection. 
Taken together, my data confirmed the important role of NF-κB and TAK1 in mounting a 
proinflammatory response during S. flexneri infection. I showed the TAK1 dependent 
activation of NF-κB in infected and in bystander cells. Furthermore, there is evidence 
that NF-κB and TAK1 activation are not required in infected cells for the production of a 
signaling molecule that triggers bystander activation. As expected, NF-κB and TAK1 
activation are essential in bystander cells for IL-8 expression during S. flexneri infection. 
Finally, I show that TAK1 is indeed activated in infected and in bystander cells of S. 
flexneri infection. 
2.2 RIPK2 contributes to IL-8 expression in bystander cells of 
S. flexneri infection 
Next, the question was addressed whether the activation of the NOD1 signaling 
pathway was required for the induction of a bystander IL-8 response during S. flexneri 
infection of HeLa cells. Because it was not possible to reduce the NOD1 mRNA levels 
sufficiently by means of RNA interference (data not shown), I depleted the adaptor 
protein RIPK2, which is required to mediate NOD1 activation to the TAK1 complex 
[108]. I used quantitative real time PCR (qRT-PCR) to control the siRNA mediated 
knock down efficiency and found a reduction of RIPK2 mRNA levels by more than 95% 
compared to control HeLa cells (Figure II.3, panel A). After infection of these cells with 
   
Results 
43 
Figure II.3 
 
A) 
 
B)      C) 
    
Figure II.3 RIPK2 contributes to IL-8 expression during S. flexneri infection. (A) RIPK2 
mRNA level after siRNA mediated knock down. HeLa cells were transfected for 72 hours with 
control or RIPK2 siRNA, respectively. RIPK2 mRNA levels were quantified by qRT-PCR. Values 
represent relative quantities (RQ) ± RQ max and RQ min of triplicate samples and indicate the 
RIPK2 mRNA level of HeLa cells depleted for RIPK2 relative to HeLa control cells after 
normalization to GAPDH mRNA; graph representative of 3 independent experiments. (B) Effect 
of RIPK2 depletion on IL-8 accumulation in bystander cells. RIPK2 depleted HeLa cells were 
infected with S. flexneri (MOI=0.5). IL-8 staining of monensin-treated HeLa cells, 3.5 hours post 
infection, IL-8 in red, S. flexneri in green, Hoechst in blue, F-actin in grey). Scale bar, 50 μm. (C) 
Effect of RIPK2 knock down, on IL-8 production in bystander cells of S. flexneri infection. HeLa 
cells depleted for RIPK2 by means of RNA interference for 72 hours and infected with S. flexneri 
(MOI=1). IL-8 staining of monensin treated cells after 3.5 hours of infection. The number of IL-8 
positive bystander cells per infection site was determined (means ± SD, N=112, representative 
of four independent experiments; *p = 1.1E-06). 
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S. flexneri at low MOI followed by automated fluorescence microscopy, the number of 
bystander cells per infection site was determined. In control cells an average of 5 ± 3 
bystander cells per infection site was found. Interestingly, RIPK2 depleted bystander 
cells of infection were still able to respond to S. flexneri infection, but only an average of 
3.3 ± 1.9 bystander cells per infection site were observed (Figure II.3, panel B and C). 
Furthermore, a mixed cell population assay was performed and the IL-8 response 
triggered by RIPK2 depleted infected cells was analyzed in control bystander cells. 
Data were not clear; either pointing to no role or a minor contribution of RIPK2 in 
infected cells in the generation of signals that trigger bystander IL-8 expression (Figure 
II.4, panel A). Analysis of the propagation of IL-8 expression induced by infected control 
cells in bystander cells depleted for RIPK2, revealed a consistently and significantly 
reduced, yet not completely blocked, fraction of IL-8 positive bystander cells at any 
given position (Figure II.4, panel B). 
Figure II.4 
 
A)       B)
 
Figure II.4 RIPK2 contributes exclusively in bystander cells to IL-8 expression. (A) Spatial 
propagation of IL-8 expression triggered from either a S. flexneri infected control cell or HeLa-
GFP cell depleted for RIPK2 into control bystander cells. Each number corresponds to the 
fraction of IL-8 producing cells for a given bystander cell position. Quantification was performed 
by automated image analysis as described previously [39] (means ± SD of 18 wells, graph 
representative of 3 independent experiments; p > 0.05 at any given position, except at BST 
position 2: p=5.2E-04). (B) Spatial propagation of IL-8 production from a S. flexneri infected 
control cell into either control bystander cells or bystander cells depleted for RIPK2. Each 
number corresponds to the fraction of IL-8 producing cells for a given bystander cell position. 
Quantification was performed by automated image analysis as described previously [39] (means 
± SD of 18 wells, graph representative of 3 independent experiments; p < 0.04 at any given 
position).  
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C) 
 
 
Figure II.4 Continued. (C) RIPK2 phosphorylation in bystander cells of S. flexneri infection. 
Whole cell lysates from HeLa cells untreated or treated with the gap junction inhibitor 18β-GA 
one hour prior infection, and infected at MOI=4 (lanes 3, 4) or at MOI=40 (lanes 5, 6, 7, 8) with 
S. flexneri ΔvirG or S. flexneri ΔvirGΔospF for 45 minutes, were analyzed by immunoblotting 
using a phospho-specific antibody that detects RIPK2 phosphorylated at serine 176 (p-RIPK2). 
Actin was used as loading control. (RES = resting cells; INF = infected cells; BST = bystander 
cells) 
 
I next investigated the phosphorylation status of the serine/threonine kinase RIPK2. It 
has been shown that RIPK2 kinase activity is required to control protein stability and 
that in absence of kinase activity, NOD1 signaling and consequently inflammatory gene 
expression was impaired [167]. Therefore, the activation status of RIPK2 in infected and 
in bystander cells was examined. I performed immunoblotting with a phospho-specific 
antibody that detects RIPK2 phosphorylated at serine 176, which is a regulatory 
autophosphorylation site in the activation loop and, which can be used to monitor the 
activation state of RIPK2 [168]. HeLa cells were either left untreated or treated with the 
gap junction inhibitor 18β-GA prior to infection. Resting cells did not show any RIPK2 
phosphorylation (Figure II.4, panel C, lanes 1 and 2). When infecting all cells with S. 
flexneri ΔvirG, no phospho-RIPK2 was detected in both conditions, indicating that 
RIPK2 was not stabilized by autophosphorylation in infected cells (Figure II.4, panel C, 
lanes 5 and 6). In the condition of 50 % infected cells (and 50 % bystander or resting 
cells, respectively), in absence of drug treatment a p-RIPK2 band was observed, which 
was sensitive to 18β-GA, indicating that RIPK2 was exclusively phosphorylated in 
bystander cells of S. flexneri infection (Figure II.4, panel D, lanes 3 and 4). As positive 
control we used a S. flexneri mutant strain depleted for OspF, which is no longer able to 
suppress RIPK2 phosphorylation in infected cells [169] (Figure II.4, panel D, lanes 7 
and 8).   
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In summary, these data indicated that RIPK2 contributes exclusively in bystander cells 
of S. flexneri infection to IL-8 expression but was not essential, implying the existence 
of a NOD1 independent signaling pathway that mediates bystander activation, or that 
NOD1 signaling was not exclusively mediated via RIPK2. Furthermore, we could show 
that RIPK2 was phosphorylated in bystander cells resulting in the stabilization of this 
protein. Hence, efficient NOD1 signaling could take place in bystander cells mediating 
IL-8 expression [167]. 
2.3 NOD1 is not required to trigger bystander activation but 
contributes to IL-8 expression in bystander cells of S. 
flexneri infection 
In order to investigate whether the activation of the NOD1 signaling pathway was 
required in the mechanism of bystander activation, I made use of two commercially 
available cell lines: human embryonic kidney cells (HEK) 293 cells stably 
overexpressing NOD1 (HEK/hNOD1) and the parental HEK 293 cell line. Since HEK 
293 cells express low levels of endogenous NOD1, residual NOD1 was depleted by 
means of small interfering RNA. These cells were used hereafter in my studies and 
referred to as HEK/null cells. I compared the mRNA levels of NOD1 in the two cell lines 
and found that they were reduced in HEK/null cells by more than 99% when compared 
to HEK/hNOD1 cells (Figure II.5, panel A). To be able to study NOD1 signaling, I 
wanted to validate that HEK/null cells indeed did not respond to the NOD1 ligand iE-
DAP. Therefore, the responsiveness of both cell lines to the acyl modified NOD1 ligand, 
C12-iE-DAP (lauroyl-γ-D-iE-DAP) was tested. The accumulation of IL-8 was visualized by 
immunofluorescence microscopy followed by automated image analysis. Very low 
concentrations of C12-iE-DAP (5 ng/ml) were sufficient to induced IL-8 production in 
HEK/hNOD1 cells, whereas HEK/null cells did not respond to the stimulus, even at very 
high concentrations such as 2.56 µg/ml (Figure II.5, panel B), showing that these two 
cell lines are a suitable model system to investigate the role of NOD1 in the molecular 
mechanism of bystander activation. 
First, I confirmed the NOD1 dependent NF-κB activation of S. flexneri infected 
HEK/hNOD1 and HEK/null cells by means of immunofluorescence. As expected, NF-κB 
activation was observed in most of infected HEK/hNOD1 cells, whereas in infected 
HEK/null cells, NF-κB activation was strongly reduced (Figure II.5, panel C).  
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Figure II.5 
 
A)     B) 
 
C) 
 
Figure II.5 NOD1 contributes to the activation of NF-κB and to bystander IL-8 expression 
during S. flexneri infection. (A) Comparison of NOD1 mRNA levels between HEK 293 cells 
over-expressing NOD1 (HEK/hNOD1) and HEK 293 cells depleted for NOD1 (HEK/null). 
HEK/hNOD1 cells and HEK/null cells were transfected with control or NOD1 siRNA, 
respectively, for 72 hours and NOD1 mRNA levels were measured by qRT-PCR. Values 
represent relative quantities (RQ) ± RQ max and RQ min of triplicate samples and indicate the 
NOD1 mRNA level of HEK/null cells relative to HEK/hNOD1 cells after normalization to GAPDH 
mRNA; graph representative of 2 independent experiments. (B) Quantification of IL-8 
accumulation in C12-iE-DAP stimulated HEK cells depleted for NOD1. HEK/hNOD1 and HEK/null 
cells were transfected with control or NOD1 siRNA, respectively, for 72 hours followed by 
stimulation with increasing concentrations of C12-iE-DAP for 5 hours. Immunofluorescence 
images were examined by automated image analysis (means ± SD of triplicate wells, graph 
representative of three independent experiments). (C) NOD1 dependent nuclear localization of 
NF-κB in infected HEK cells. HEK/hNOD1 cells were treated with control siRNA and HEK/null 
cells with NOD1 siRNA for 72 hours. Cell layers were infected for 50 minutes with S. flexneri 
(MOI=1) and stained with a p65 antibody. NF-κB translocation was detected by fluorescence 
microscopy and manually quantified (results represent the mean ± SD of triplicate wells; 
HEK/hNOD1: N= 154; HEK/null: N=195; graph representative of 3 independent experiments, *p 
= 2.5E-04).  
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Subsequently, single infection sites were investigated in order to determine the role of 
NOD1 in bystander cells. In HEK/hNOD1 cell layers an average of 9.9 ± 0.85 NF-κB 
positive bystander cells per infection site were found. HEK cells depleted for NOD1 
were still able to respond to infection, but the number of NF-κB positive bystander cells 
per infection site (5.2 ± 1.11) was significantly reduced (Figure II.5, panel D and E). 
Given that NF-κB controls IL-8 expression, a reduced number of IL-8 positive bystander 
cells was expected. This assumption was confirmed and a reduced number of IL-8 
positive bystander cells per infected cell in HEK/null cells (8.3 ± 1.4) compared to 
HEK/hNOD1 cells (14.8 ± 1.6) (Figure II.5, panel F and G) was observed. These 
findings are in line with the RIPK2 data in HeLa cells, and suggest the existence of a 
NOD1 independent signaling pathway that contributes to bystander IL-8 expression. 
Figure II.5 
 
D)           E) 
       
F)           G) 
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Figure II.5 Continued. (D) NOD1 dependent bystander NF-κB activation in HEK cells infected 
with S. flexneri. HEK/hNOD1 cells and HEK/null treated for 72 hours with control or NOD1 
siRNA, respectively, were infected with S. flexneri (MOI=0.1) for 50 minutes, stained with p65 
antibody (NF-κB in red, S. flexneri in green). Scale bar represents 25 µm (E) Quantification of 
NOD1 dependent NF-κB activation in bystander cells of S. flexneri infection, the number of NF-
κB positive bystander cells per infection site was determined by automated image analysis 
(means ± SD of 9 wells, graph representative of three independent experiments; *p = 2.6E-08). 
(F) NOD1 dependent bystander IL-8 expression of HEK cells infected with S. flexneri. HEK 
hNOD1 cells and HEK/null cells treated for 72 hours with control or NOD1 siRNA, respectively, 
were infected with S. flexneri (MOI=0.1) for 3.5 hours and stained with an IL-8 antibody and 
Hoechst (IL-8 in red, S. flexneri in green, Hoechst in blue). Scale bar represents 25 µm. (G) 
Quantification of NOD1 dependent IL-8 expression in bystander cells of S. flexneri infection. The 
number of IL-8 positive bystander cells per infection site was determined by automate image 
analysis (means ± SD of 9 wells, graph representative of three independent experiments; *p = 
8.2E-08). 
 
 
In order to perform a mixed cell population assay a HEK 293 cell line stably expressing 
GFP was generated. Control experiments were performed to select a HEK/null-GFP cell 
line that responded similarly to S. flexneri infection as the parental HEK 293 cell line 
used in the previous experiments. These cells were used in a mixed cell population 
assay to assess the requirement of NOD1 signaling in infected cells for the production 
of a signaling molecule that mediates bystander activation and to assess the role of 
NOD1 in bystander cells for IL-8 expression. By means of immunofluorescence 
microscopy, mixed cell layers consisting of few NOD1 depleted cells (HEK/null-GFP) 
surrounded by a majority of NOD1 overexpressing bystander cells (HEK/hNOD1) were 
analyzed. Unexpectedly, S. flexneri infected HEK/null-GFP cells induced in 
HEK/hNOD1 bystander cells the same IL-8 response (red curve) as an infected 
HEK/hNOD1 cell (black curve), indicating that NOD1 signaling in infected cells was not 
required to trigger the signals that lead to bystander activation (Figure II.6, panel A top, 
IF image; bottom, quantification). Analysis of infected cell layers consisting of few 
HEK/hNOD1 cells surrounded by a majority of HEK/null-GFP cells revealed that NOD1 
contributes in bystander cells to IL-8 expression (FigureII.6, panel B top, IF image; 
bottom, quantification). Of note, in two mixed cell population assays the IL-8 response 
of HEK/null-GFP bystander cells was stronger decreased as compared to the IL-8 
response of parental HEK/null cells, whereas in one mixed cell population experiment 
the IL-8 response of HEK/null-GFP bystander cells was not significantly reduced. I 
assume that by repeating the mixed cell population experiment the data of the parental 
HEK/null cell line can be reproduced. 
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Figure II.6 
 
A)          B) 
 
 
Figure II.6 NOD1 is not required to trigger bystander activation but contributes to IL-8 
expression in bystander cells of S. flexneri infection. (A+B, top) One representative IF 
image (HEK/hNOD1 in blue, HEK/null in green, S. flexneri in yellow, IL-8 in red), scale bar 
represents 25 µm. (A, bottom) Spatial propagation of IL-8 expression triggered from either a S. 
flexneri infected HEK/hNOD1 cell or a HEK/null-GFP cell depleted for NOD1 into HEK/hNOD1 
bystander cells. Infection of mixed cell layers at MOI=0.02. Each number corresponds to the 
fraction of IL-8 producing cells for a given bystander cell position. Quantification was performed 
by automated image analysis as described previously [39] (means ± SD of 18 wells, graph 
representative of 3 independent experiments; p > 0.24 at any given position). (B, bottom) 
Spatial propagation of IL-8 production from a S .flexneri infected HEK/hNOD1 cell into either 
HEK/hNOD1 bystander cells or HEK/null-GFP bystander cells depleted for NOD1. Each number 
corresponds to the fraction of IL-8 producing cells for a given bystander cell position. 
Quantification was performed by automated image analysis as described previously [39] (means 
± SD of 18 wells, graph representative of 3 independent experiments; p < 1.1E-16). (IF = 
immunofluorescence microscopy, INF = infected cells; BST = bystander cells) 
 
Taken together, these results showed that NOD1 contributes in bystander cells of S. 
flexneri infection to IL-8 expression, while in infected cells the activation of the NOD1 
dependent signaling pathway is not required to trigger bystander activation. In line with 
the data gained on RIPK2 in HeLa cells, these data imply the existence of a NOD1 
independent signaling pathway in bystander cells, which contributes to bystander IL-8 
expression. 
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2.4 TIFA and TRAF6 are required exclusively in bystander cells 
for IL-8 expression 
In the frame of the InfectX project, a genome-wide RNAi screen was performed in order 
to study various aspects of Shigella virulence, including bystander IL-8 production 
(performed by C.A. Kasper). Primary hits from the genome-wide screen were validated 
in a secondary screen resulting in a list of candidate proteins that could be involved in 
bystander IL-8 expression. Among these the Na+/K+-ATPase (ATP1A1), the TRAF-
interacting protein with a FHA domain (TIFA) and the TNF receptor-associated factor 6 
(TRAF6) were investigated in more detail. The ion pump Na+/K+-ATPase is an 
ubiquitous enzyme located at the plasma membrane, which is involved in maintaining 
the cell membrane potential. TRAF6 is an E3 ubiquitin ligase that is known to activate 
TAK1 and subsequently NF-κB and the MAPKs downstream of various receptors 
including TNF and Toll-like receptors [170]. Finally, TIFA was shown to interact with 
TRAF6 in TNFα-stimulated cells leading to NF-κB activation [171]. S. flexneri infected 
HeLa cell layers depleted either for TRAF6 or for TIFA were not able to activate NF-κB 
in bystander cells and consequently no IL-8 production was observed (C.A. Kasper, 
unpublished data). In contrast, HeLa cells depleted for ATP1A1 were still able to 
activate NF-κB in bystander cells, while at the same time no bystander IL-8 production 
was observed (C. Kasper, unpublished data). We hypothesized that depletion of 
ATP1A1 could interfere with the osmoregulation of the cell and thereby could inhibit 
protein synthesis in general [172]. Thus, we did not follow up on ATP1A1 but instead 
focused on the other two hits. 
First, I controlled the knock down efficiency of TRAF6 and TIFA by means of qRT-PCR. 
The mRNA levels for both TRAF6 and TIFA were reduced by 92 ± 2% (Figure II.7, 
panel A and B). Next, we controlled the specificity of the siRNA mediated depletion of 
TRAF6 and TIFA, with a rescue experiment, in which TRAF6 or TIFA, respectively, 
were rescued by transient transfection of a siRNA resistant variant (2 to 3 silent 
mutations in the siRNA seed region). This experiment confirmed that IL-8 expression 
during S. flexneri infection in cells depleted for TRAF6 or TIFA, respectively, could be 
rescued (C.A. Kasper, unpublished data, not shown). 
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Figure II.7 
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Figure II.7 TIFA and TRAF6 are essential for bystander IL-8 expression. (A + B) Control of 
siRNA mediated TRAF6 and TIFA knock down. HeLa cells were transfected for 72 hours with 
the respective siRNA. TRAF6 or TIFA mRNA levels were measured by quantitative real-time 
PCR. Values represent relative quantities (RQ) ± RQ max and RQ min of triplicate samples and 
indicate the TRAF6 or TIFA mRNA level of HeLa cells depleted for TRAF6 or TIFA, respectively, 
relative to HeLa control cells after normalization to GAPDH mRNA; graph representative of 1 
experiment. (C) Spatial propagation of IL-8 expression triggered from either a S. flexneri infected 
control cell or HeLa-GFP cell depleted for TRAF6 (left) or TIFA (right) into control bystander 
cells. Mixed cell layers were infected at MOI=0.02. Quantification was performed by automated 
image analysis as described previously [39]. Each number corresponds to the fraction of IL-8 
producing cells for a given bystander cell position (means ± SD of 18 wells, graph representative 
of 3 independent experiments; TRAF6: p > 0.18 at any given position; TIFA: p > 0.25 at any 
given position). (D) Spatial propagation of IL-8 production from an infected control cell into either 
control bystander cells or HeLa-GFP bystander cells depleted for TRAF6 (left) or TIFA (right). 
Mixed cell layers were infected at MOI=0.02. Each number corresponds to the fraction of IL-8 
producing cells for a given bystander cell position. Quantification was performed by automated 
image analysis as described previously [39] (means ± SD of 18 wells, graph representative of 3 
independent experiments; TRAF6: p < 1.4E-05 at any given position; TIFA: p < 1.6E-05 at any 
given position). 
 
To discriminate between signaling events taking place in infected and in bystander cells 
a mixed cell population assay was performed. Automated analysis of 
immunofluorescence images revealed that infected cells depleted for TRAF6 or TIFA, 
triggered the same bystander IL-8 response in control bystander cells (red curve) as an 
infected control cell (black curve) (Figure II.7, panel C). In contrast, TRAF6 or TIFA 
depleted bystander cells, of infected control cells were not able to express IL-8 (Figure 
II.7, panel D). These data point to a role for TRAF6 and TIFA exclusively in bystander 
cells of S. flexneri infection, while signals that trigger bystander activation in infected 
cells are generated independently of TIFA and TRAF6. 
As TRAF6 is a known activator of TAK1 [170] and TIFA is known to activate TRAF6 
[171], I tested, whether TAK1 activation in infected and in bystander cells of S. flexneri 
infection was TRAF6 and/or TIFA dependent. This was done by means of 
immunoblotting with the phospho-specific antibody described previously. Upon knock 
down of TRAF6 or TIFA, HeLa cells were left untreated or treated with the gap junction 
inhibitor 18β-GA prior to infection. Analysis of lysates of HeLa cells depleted for TRAF6 
revealed that TAK1 activation in S. flexneri infected cells and in bystander cells was 
completely TRAF6 dependent (Figure II.7, panel E and F, lanes 11 and 12). HeLa cells 
depleted for TIFA showed in infected and in bystander cells a reduced TAK1 activation 
(Figure II.7, panel E and F, lanes 7 and 8). 
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Figure II.7 
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Figure II.7 Continued. (E) TRAF6 and TIFA dependent activation of TAK1 in S. flexneri infected 
HeLa cells and bystander cells. HeLa cells were transfected with control, TIFA or TRAF6 siRNA 
for 72 hours, 1 hour prior infection with S. flexneri at MOI=4, cells were treated or not with the 
gap junction inhibitor 18β-GA. After 45 minutes of infection cells were lysed and analyzed by 
immunoblotting using a p-TAK1 (T187) antibody. Actin was used as loading control. (F) 
Densitometric quantification of phosphorylated TAK1 in control cells and TIFA or TRAF6 
depleted HeLa cells. Graph representative of 2 independent experiments. (RES = resting cells; 
INF = infected cells; BST = bystander cells) 
 
Altogether, these data indicate that the signals underlying cell-cell communication are 
produced independently of TIFA or TRAF6 activation in infected cells, while in 
bystander cells, TIFA and TRAF6 are essential for IL-8 expression. Furthermore, the 
data indicates that in bystander cells TAK1 activation is partially TIFA dependent and 
completely TRAF6 dependent. 
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2.5 NOD1 signals partially in a TIFA/TRAF6-dependent manner 
to TAK1 in bystander cells 
The E3 Ub ligase TRAF6 gets activated downstream of various receptors, such as IL-
1Rs, TLRs or TNFRs, and signals then to TAK1 [170]. Furthermore, it is known to be 
activated by TIFA upon TNFα stimulation. Therefore, we examined whether 
TIFA/TRAF6 were activated downstream of NOD1 or whether they formed part of a 
second signaling pathway contributing to IL-8 expression in bystander cells of S. 
flexneri infection. To address this question, I used the HEK/hNOD1 cell line that can be 
stimulated selectively with the NOD1 ligand iE-DAP. First, TRAF6, TIFA or TAK1, 
respectively, were depleted by means of RNA interference in HEK/hNOD1 cells, and 
the knock down efficiency was confirmed by qRT-PCR. Indeed, a significant reduction 
of mRNA levels compared to control cells of 91 ± 2%, 93 ± 1% and 94 ± 3%, could be 
found for all three knock downs (Figure II.8, panel A). Thereafter, HEK/hNOD1 cells 
depleted for TIFA, TRAF6 or TAK1, were either infected with S. flexneri or were 
stimulated with the NOD1 ligand C12-iE-DAP and the proinflammatory responses 
elicited by the differently stimulated cells was compared. Automated image analysis of 
immunofluorescence images was used to determine the fraction of NF-κB positive and 
the fraction of IL-8 positive cells during S. flexneri infection or in C12-iE-DAP treated 
cells. In line with our HeLa data, TAK1 depletion in HEK/hNOD1 cells severely impaired 
proinflammatory signals in bystander cells of infection with a reduction of the fraction of 
NF-κB p65 positive bystander cells by 87% (Figure II.8, panel B left) and a reduction of 
IL-8 positive bystander cells by 76% (Figure II.8, panel B right) compared to control 
cells. Selective stimulation of the NOD1 signaling pathway with C12-iE-DAP of 
HEK/hNOD1 cells depleted for TAK1, revealed a reduction of NF-κB positive bystander 
cells by 85% (FigureII.8, panel B left) and subsequently a reduction of IL-8 positive 
bystander cells by 82% compared to control cells (FigureII.8, panel B right). In 
summary, these data show that the majority of proinflammatory signals in bystander 
cells of S. flexneri infection converge on TAK1. 
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Figure II.8 
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Figure II.8 NOD1 signals partially in a TIFA/TRAF6 dependent manner to TAK1 in 
bystander cells. (A) Control of siRNA mediated TIFA, TRAF6 and TAK1 knock down in 
HEK/hNOD1 cells. HEK/hNOD1 cells were transfected for 72 hours with the respective siRNA. 
TIFA, TRAF6 or TAK1 mRNA levels were measured by qRT-PCR. Values represent relative 
quantities (RQ) ± RQ max and RQ min of triplicate samples and indicate the mRNA level of 
HEK/hNOD1 cells depleted for TIFA, TRAF6 or TAK1 relative to HEK/hNOD1 control cells after 
normalization to GAPDH mRNA; graph representative of 1 experiment for RIPK2 and TIFA and 
2 experiments for TRAF6 and TAK1. (B) S. flexneri and C12-iE-DAP stimulated HEK/NOD1 cells 
require TAK1 for NF-κB activation and IL-8 expression. HEK/hNOD1 cells treated for 72 hours 
with control or TAK1 siRNA were infected with S. flexneri at MOI=0.1 or stimulated with C12-iE-
DAP (500 ng/ml). Cells were either fixed after 50 minutes and stained with a p65 antibody, or 
fixed after 3.5 hours and stained with an IL-8 antibody. The fraction of NF-κB positive BST (left) 
or IL-8 positive BST (right) was determined by automated image analysis [39] (means ± SD of 9 
wells, graph representative of three independent experiments; NF-κB: *p = 6.5E-09; **p = 2.9E-
04; IL-8: *p = 1.9E-12, **p = 8.9E-04). 
Bystander cells of S. flexneri infection of HEK/hNOD1 cells depleted for TRAF6 showed 
upon infection a reduction of the fraction of NF-κB p65 positive bystander cells by 34% 
(Figure II.8, panel C left) and a reduction of IL-8 positive bystander cells by 41% 
compared to control cells (Figure II.8, panel C right). Noteworthy, the loss in NF-κB 
activation and IL-8 production in HEK/hNOD1 cells is, in contrast to the knock down in 
HeLa cells, not complete. This can be explained by the fact that NOD1 is over-
expressed in HEK/hNOD1 cells compared to HeLa cells and proinflammatory signals 
are mediated via the classical NOD1-RIPK2 signaling pathway. Interestingly, 
stimulation of the NOD1 signaling pathway with C12-iE-DAP in HEK/hNOD1 cells 
depleted for TRAF6, revealed a strong reduction of NF-κB positive bystander cells by 
75% (Figure II.8, panel C left) and subsequent reduction of IL-8 positive bystander cells 
by 71% compared to control cells (Figure II.8, panel C right). This data suggest that 
NOD1 signals in a TRAF6 dependent manner to TAK1. 
Next, we analyzed TIFA depleted HEK/hNOD1 bystander cells of S. flexneri infection 
and found a reduction of the fraction of NF-κB p65 positive bystander cells by 35% 
(FigureII.8, panel D left) and a reduction of IL-8 positive bystander cells by 46% 
compared to control cells (FigureII.8, panel D right). Similar to the TRAF6 knock down, 
the discrepancy of TIFA data gained in HeLa and HEK/hNOD1 cells might be explained 
by the over expression of NOD1 in HEK cells. Stimulation of the NOD1 signaling 
pathway with C12-iE-DAP of HEK/hNOD1 cells depleted for TIFA revealed a reduction 
of NF-κB positive bystander cells compared to control cells by 64% (FigureII.8, panel D 
left) and a reduction of IL-8 positive bystander cells compared to control cells by 48% 
(Figure II.8, panel D right). These results suggest that NOD1 signaling is partially TIFA 
dependent.  
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Figure II.8 
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Figure II.8 Continued. (C) NOD1 signaling in response to S. flexneri infection is partially TRAF6 
dependent. HEK/hNOD1 cells were treated for 72 hours with control or TRAF6 siRNA and 
infected with S. flexneri at MOI=0.1 or stimulated with C12-iE-DAP (500 ng/ml). Cells were either 
fixed after 50 minutes and stained with a p65 antibody, or fixed after 3.5 hours and stained with 
an IL-8 antibody. The fraction of NF-κB positive BST (left) or IL-8 positive BST (right) was 
determined by automated image analysis [39] (means ± SD of 9 wells, graph representative of 
three independent experiments; NF-κB: *p = 5.9E-03; **p = 4.7E-04; IL-8: *p = 4.3E-07; **p = 
5.2E-03). (D) TIFA contributes to NOD1 signaling in S. flexneri infected HEK/hNOD1 cells. 
HEK/hNOD1 cells treated for 72 hours with control or TIFA siRNA respectively, infected with S. 
flexneri at MOI=1 or stimulated with C12-iE-DAP (100 ng/ml). Cells were either fixed after 50 
minutes and stained with a p65 antibody, or fixed after 3.5 hours and stained with an IL-8 
antibody. The fraction of NF-κB positive BST (left) or IL-8 positive BST (right) was determined by 
automated image analysis (means ± SD of 3 wells, graph representative of two independent 
experiments for NF-κB and five independent experiments for IL-8; NF-κB: *p = 1.5E-03; **p = 
1.0E-02; IL-8: *p = 1.3E-04; **p = 1.3E-03). (E) Model describing signaling taking place in 
bystander cells upon S. flexneri infection or C12-iE-DAP stimulation of epithelial cells. 
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Figure II.8 
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In summary, these data indicate that NOD1 signals in bystander cells of S. flexneri 
infection partially in a TIFA and TRAF6 dependent manner to TAK1, which in turn is 
essential for NF-κB activation and subsequent IL-8 expression (Figure II.8, panel E). 
2.6 S. flexneri induced intercellular calcium signaling 
contributes to bystander IL-8 production, but does not 
affect NF-κB activation 
Cell–cell communication between adjacent cells during S. flexneri infection is mediated 
via gap junctions and depends on the diffusion of small molecules (< 1 – 2 kDa) such 
as ions, second messengers, nucleotides amino acids and metabolites. In order to 
identify the small diffusing molecules responsible for bystander activation during S. 
flexneri infection, we started a collaboration with the group of J.A. Vorholt (ETHZ) who 
had developed different methods to identify and quantify metabolites and small 
molecules using LC-HRMS. The idea was to compare the levels of small molecules in 
resting and infected cells within the first 30 minutes of S. flexneri infection. The results 
from the 2 first LC-HRMS experiments revealed an increase of cAMP and cGMP after 
infection, suggesting that these two second messengers could be important for cell-cell 
communication. As these data were also accompanied by an increase in inositol 1,4,5-
trisphosphate (IP3) and hepoxilin A3, molecules known to be produced upon S. flexneri 
infection, we pursued this hypothesis and determined the level of cAMP and cGMP 
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after infection. Yet, measurements by ELISA indicated no increase in the concentration 
for cAMP and cGMP (data not shown). In addition, reanalysis of the two first LC-HRMS 
datasets with newly developed analysis tools had in the meantime disproved an 
increase of cAMP and cGMP after S. flexneri infection. As the method itself turned out 
not to be sensitive and robust enough to measure significant concentration differences 
of small molecules such as cAMP and cGMP, we went on with the hypothesis driven 
approach. 
It is reported that Shigella induces calcium waves involving IP3-dependent opening of 
internal calcium stores [173]. In the field of cell physiology, it is suggested that IP3-
induced gap junction mediated intercellular calcium ion waves may represent a general 
mechanism, by which cells do communicate and coordinate multicellular responses 
[158]. Furthermore, we found that the NOD1 receptor contributed in bystander cells of 
S. flexneri infection to IL-8 expression. Thus, we combined this knowledge, and 
hypothesized that the IP3-induced calcium waves together with the NOD1 ligand iE-
DAP could trigger bystander IL-8 expression. To test this hypothesis we performed co-
stimulation experiments in HeLa and HEK NOD1 overexpressing cells. We stimulated 
the cells with C12-iE-DAP and challenged them in addition with ionomycin, which 
triggers calcium. HeLa or HEK/hNOD1 cells, respectively, stimulated with ionomycin 
alone did not produce IL-8, while stimulation with C12-iE-DAP induced IL-8 production in 
HeLa and in HEK/hNOD1 cells. Upon co-stimulation of HeLa or HEK/hNOD1 cells with 
C12-iE-DAP and ionomycin the IL-8 response was potentiated (Figure II.9, panel A). 
Based on these data we hypothesized that IP3-induced calcium waves together with iE-
DAP released from replicating S. flexneri could be the trigger for bystander IL-8 
expression. 
Figure II.9 
A) 
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Figure II.9 Shigella flexneri induced increase in the intracellular [Ca
++
] seems to 
contribute to bystander IL-8 secretion, but does not affect NF-κB activation. (A) 
Intracellular calcium increase potentiates DAP dependent IL-8 production. HeLa (left) and 
HEK/hNOD1 cells (right) were stimulated with C12-iE-DAP (10 µg/ml) for 5 hours, after 2 hours 
ionomycin (1µM) was added for the remaining three hours. Immunofluorescence images were 
analyzed by automated image analysis and the fraction of IL-8 producing cells was determined. 
(means ± SD of 3 wells, graph representative of one experiment (B) NF-κB activation is 
independent of calcium signaling. HeLa cells were pretreated with the calcium chelator BAPTA-
AM (left) at 20 µM or the IP3 receptor inhibitor 2-APB (right) at 50 µM for 30 minutes, and 
infected with S. flexneri at MOI=1, after infecting cells inhibitor concentrations were as follows:10 
µM and 25 µM, respectively. 30 minutes p.i. BAPTA-AM was removed 1 hour p.i. due to avoid 
toxicity. Cells were fixed and stained with a p65 antibody. The nuclear translocation of NF-κB 
p65 was analyzed by automated image analysis and the nuclear/cytoplasmic p65 intensity ratio 
was calculated as described in [39]. The data shown are mean values +/- SD of triplicate wells 
per condition; graph representative of 2 independent experiments. (C) IL-8 expression in 
bystander cells of S. flexneri infection depends on calcium release from internal stores. HeLa 
cells treated with BAPTA-AM at 20 µM (left) or with 2-APB at 50 µM (right) 30 minutes prior to 
infection, were infected with S. flexneri (MOI=1), p.i. inhibitor concentrations were divided into 
halve: 10 µM and 25 µM, respectively. BAPTA-AM was removed 1 hour p.i. in order to avoid 
toxicity. After 3.5 hours cells were fixed and stained with an IL-8 antibody. The fraction of IL-8 
positive BST was determined by automated image analysis (means ± SD of 3 wells, graph 
representative of two independent experiments; *p = 2.7E-03).  
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To further investigate the impact of calcium signaling, we did live cell imaging. HeLa 
cells that were loaded with the calcium indicator Fluo4-AM were challenged with S. 
flexneri. Calcium waves were monitored over the first 15 minutes of infection. S. flexneri 
indeed induced calcium waves that were BAPTA-AM (BAPTA-AM, a chelater of 
intracellular calcium ions) sensitive and could in addition be blocked by inhibition of the 
IP3 receptor with 2-APB (I. Sorg, data not shown). Next, we treated HeLa cells with 
either BAPTA-AM or the IP3 receptor inhibitor 2-APB and infected them with S. flexneri 
for 50 minutes or 3.5 hours and stained for NF-κB or IL-8, respectively. Inhibition of 
calcium waves by BAPTA-AM treatment (Figure II.9, panel B left) or IP3 receptor 
inhibition with 2-APB (Figure II.9, panel B right) did not affect NF-κB activation in 
bystander cells. The finding that NF-κB activation in bystander cells was not calcium 
signaling dependent additionally indicated that the BAPTA-AM and 2-APB had no 
inhibitory effect on gap junction mediated cell–cell communication. Yet, we observed a 
significantly reduced bystander IL-8 response upon BABTA-AM treatment (Figure II.9, 
panel C left) as well as upon IP3 receptor inhibition with 2-APB (Figure II.9, panel C 
right). These data indicate that S. flexneri induced calcium waves contribute to 
bystander IL-8 expression. 
S. flexneri is known to mediate the phosphatidylinositol 5-phosphate (PI5P) dependent 
activation of the epidermal growth factor receptor (EGFR) signaling pathway [174]. One 
branch of signaling downstream of EGFR leads to PI3-kinase and AKT activation, 
whereas the second branch leads to PLCγ1 activation, which catalysis the cleavage of 
phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and 
diacylglycerol (DAG). To test the possibility that PLCγ1 was involved in the process of 
bystander IL-8 expression, we treated HeLa cells prior to infection with the PLCγ1 
inhibitor U73122 and monitored the NF-κB activation and IL-8 expression in bystander 
cells of infection. Because U73122 treatment affected the infection rate, C.A. Kasper 
determined the fraction of NF-κB positive and IL-8 positive cells at bystander positions 1 
to 5, when infecting cells at very low MOI. As expected, we observed no impact of 
PLCγ1 inhibition at the level of NF-κB activation in bystander cells of S. flexneri 
infection (Figure II.10, panel A), whereas the fraction of IL-8 producing bystander cells 
was significantly reduced (Figure II.10, panel B), suggesting a role for PLCγ1 in the 
process of bystander IL-8 production. 
Taken together, our data indicate a role for calcium signaling in the process of 
bystander IL-8 expression, which might be mediated via the activation of PLCγ1 in 
infected cells. 
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Figure II.10 
 
A)        B) 
 
 
Figure II.10 PLCγ1 signaling contributes to bystander IL-8 expression. (A) NF-κB activation 
during S. flexneri infection is PLCγ1 independent. HeLa cells were treated with U73122 at 10 µM 
30 min prior infection up to 1 p.i. Cells were infected with S. flexneri at MOI=0.02. After 1 hour of 
infection cells were fixed and stained for NF-κB p65 subunit. The nuclear translocation of NF-κB 
p65 was monitored by immunofluorescence and quantified by automated image analysis. The 
nuclear/cytoplasmic p65 intensity ratio was calculated as described in [39] (means ± SD of 3 
wells, graph representative for one experiment). (B) IL-8 expression is PLC γ1 dependent. HeLa 
cells were treated with U73122 at 10 µM 30 min prior infection up to 1 hour p.i. and at 5 µM until 
fixation. Cells were infected with S. flexneri at MOI=0.02 for 3.5 hours, fixed and stained with an 
IL-8 antibody. IL-8 accumulation was monitored by automated imaging. The fraction of IL-8 
positive BST at position 1 to 5 was determined by automated image analysis (means ± SD of 3 
wells, graph representative for two independent experiments). 
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1 Cell lines  
HeLa cells were purchased from ATCC. HEK293/null and HEK293/hNOD1 cells were 
obtained from Invivogen (San Diego, USA). All cell lines were cultivated in DMEM, 
supplemented with 10% FCS, antibiotics and 2 mM L-glutamine. HeLa and HEK293/null 
cells stably expressing GFP were kindly provided by Dr. R. Okujava (Biozentrum, 
University of Basel, Switzerland). 
2 Antibodies and Reagents 
Antibody against NF-κB p65 was purchased from Santa Cruz Biotechnology (Santa 
Cruz, USA). Anti human IL-8 antibody was obtained from BD Pharmingen (San Jose, 
USA). Phospho-TAK1 antibody was purchased from Cell Signaling (Danvers, USA), 
Alexa Fluor 647-coupled anti-mouse IgG antibody and Hoechst 33342 were obtained 
from Invitrogen (Carlsbad, USA). DY-495-Phalloidin was purchased from Dyomics 
(Jena, Germany). C12-iE-DAP was purchased from Invivogen (San Diego USA).The 
antibody against actin was purchased from Millipore (Billerica, USA). Monensin, 18β 
glycyrrethinic acid (18β-GA), Poly-D-lysine, 2-APB and U73122 were obtained from 
Sigma-Aldrich (St. Louis, USA). BABTA-AM was purchased from Fluka/Sigma-Aldrich 
(St. Louis, USA). 
3 Bacterial strains 
The icsA (virG) deletion mutant (∆virG) generated in the M90T S. flexneri 2a strain was 
generously provided by Dr. P. Sansonetti (Institut Pasteur, Paris, France). The ΔvirG 
ΔospF mutant was generated as previously described [175] In addition, all S. flexneri 
strains were transformed with the pMW211 plasmid to express the DsRed protein under 
control of a constitutive promoter. The pMW211 plasmid was a generous gift from Dr. 
D. Bumann (Biozentrum, University of Basel, Switzerland).  
4 Small interfering RNA (siRNA) reverse transfection 
protocol 
NOD1 siRNA was purchased from Santa Cruz Biotechnology (Santa Cruz, USA). 
RIPK2, TIFA and TRAF6 siRNAs were obtained from Ambion (Carlsbad, USA). p65 
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human RELA (NF-κB subunit), TAK1 and scrambled siRNAs were purchased from 
Dharmacon (Dallas, USA). Transfection of siRNAs was carried out using RNAimax 
(Invitrogen, Carlsbad, USA). Cells, seeded in a 6-well plate (200’000 HEK or 250’000 
HeLa cells/well), were reversely transfected with 40 nM siRNA according to the 
manufacturer’s instruction. Cells were harvested after 48 hours and seeded into 96 well 
plates (3.65E5 HEK/null, 4.35E5 HEK/hNOD1 and 1.35E5 HeLa cells/ml) and used 24 
hours later. For HEK cell experiments 96 well plates were coated with poly-D-lysin 
before use. Briefly, 96 well plates were incubated for 1 hour with 10 µg/ml poly-D-lysin 
in PBS. Then the poly-D-lysine solution was removed and the plates were washed 4 
times with PBS, dried for 1 hour at room temperature, and finally were stored at 4°C 
until use. 
5 Mixed cell population assay 
For the mixed HeLa cell population experiments, HeLa-GFP cells were transfected with 
specific siRNAs and HeLa cells with control siRNA for 48 hours. After harvesting of the 
two cell populations the cell number was adjusted to 1.35E5 cells/ml for both cell 
populations. Next, HeLa-GFP depleted for a protein of interest and HeLa control cells 
were mixed at ratios 1 to 5 and 5 to 1 and seeded into a 96 well plate, per well 150 µl 
cell suspension were added. Per condition 21 wells were seeded, 18 wells for infections 
at MOI=0.02 and 3 wells served as uninfected controls. After another 24 hours of 
incubation, the experiment was performed. 
For the mixed HEK cell assay, HEK-GFP cells were treated with NOD1 siRNA and 
HEK/hNOD1 cells with control siRNA for 48 hours. The two cell populations were 
harvested and the cell number was adjusted to 3.65E5 cells /ml cells for HEK-GFP cells 
and to 4.35E5 cells/ml for HEK/hNOD1 cells. Next, the two cell populations were mixed 
at ratios1 to 5 and 5 to 1 and seeded into a poly-D-lysin coated 96 well plate, per well 
150 µl cell suspension were added. Per condition 21 wells were seeded, 18 wells for 
infections at MOI=0.02 and 3 wells served as uninfected controls. After another 24 
hours of incubation, the experiment was performed. 
6 Infection assay 
S. flexneri strains were grown in tryptic soy broth (TSB) to exponential log phase at 
37°C and coated with poly-L-lysine before infection. 30 minutes before infection, 
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complete growth medium was replaced by DMEM supplemented with 10 mM Hepes 
and 2 mM L-glutamine (assay medium). In the case of inhibitor treatment, 60 minutes 
prior infection the medium was replaced and 18β-GA was added at 2x concentration 
(10 µM). BAPTA-AM, 2-APB and U73122 were added 30 minutes prior infection at the 
indicated concentrations. Bacteria were added to cells at the indicated MOI. Infection 
was initiated by centrifuging the plates for 5 minutes and incubating at 37°C for the 
indicated time periods. Extracellular bacteria were killed by adding gentamycin (50 
μg/ml) 30 minutes after infection and IL-8 secretion was prevented by adding monensin 
(50 µM) 30 minutes p.i. 
7 SDS-PAGE and immunoblotting 
Cells were washed twice in ice cold PBS, lysed in PhosphoSafeTM extraction reagent 
Novagen (Darmstadt, Germany) supplemented with 1x protease inhibitor cocktail 
Calbiochem (Darmstadt, Germany), incubated on ice for 10 minutes, and subsequently 
centrifuged at 4°C for 20 minutes at 16’000g. The protein concentration was determined 
by the use of the Protein Assay kit Pierce (Rockford, USA). 10-15 µg of protein were 
resolved on SDS-polyacrylamide gels and electroblotted onto Hybond C-Extra 
nitrocellulose membrane from Amersham Bioscience (Pittsburgh, USA). Immunoblotting 
was performed using primary antibodies diluted in phosphate buffered saline containing 
0.1% tween and 5% bovine serum albumin. For detection of primary antibodies HRP-
conjugated secondary antibodies from GE Healthcare (Chalfont St Giles, United 
Kingdom) or Cell signaling technology (Danvers, USA) were used. The blots were 
developed with an enhanced chemiluminescence method from Pierce (Rockford, USA) 
using an ImageQuant LAS4000 digital imaging system from GE Healthcare (Chalfont St 
Giles, United Kingdom). Finally, images were analyzed by densitometry. 
8 Immunofluorescence 
Cells were fixed with 4% paraformaldehyde in PBS. For the visualization of NF-κB 
localization, cells were first incubated for 1 hour in blocking buffer (1xPBS/ 5% goat 
serum/ 0.3% Triton X-100) followed by the incubation with a monoclonal mouse anti-
p65 antibody in antibody dilution buffer (1xPBS/ 1% BSA/ 0.3% Triton X-100; 1:250) 
overnight at 4°C. After washing with PBS, cells were stained with Alexa Fluor 647-
coupled goat anti-mouse IgG in antibody dilution buffer (1:500). Cell nuclei were stained 
with Hoechst (HeLa 1:2500, HEK 1:1000). IL-8 was visualized by adding a monoclonal 
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mouse anti human IL-8 antibody in saponin buffer (1xPBS/ 0.2% saponin; 1:300) for 2 
hours at room temperature. After washing with PBS, cells were incubated with Alexa 
Fluor 647-coupled goat anti-mouse IgG diluted in saponin buffer (1:500). Nuclei and F-
actin were stained with Hoechst (HeLa 1:2500, HEK 1:1000) and DY-495-Phalloidin 
(1:400), respectively. 
9 Automated microscopy and image analysis 
Images were automatically acquired with an ImageXpress Micro (Molecular devices, 
Sunnyvale, USA). At each site, images at 360nm, 480nm, 594nm and 640nm were 
acquired to visualize Hoechst, GFP expression or phalloidin F-actin, DsRed expressing 
S. flexneri and Alexa Fluor 647-coupled secondary antibodies. Image analysis was 
performed with CellProfiler and MATLAB (The MathWorks, Inc, Natick, USA) as 
described previously [39, 176] (see V Appendix). 
10 Quantitative real-time PCR 
The level of various mRNAs was measured by quantitative real-time PCR (qRT-PCR) 
as follows. Total RNA was isolated from cells treated with control or target specific 
siRNA for 72 hours using the RNeasy Mini Kit and RNase-Free DNase Set (Quiagen, 
Hilden, Germany). Total RNA was reverse transcribed using oligo(dT)15 primer 
(Promega) with Superscript III reverse transcriptase (Invitrogen). qRT-PCR was 
performed on StepOne Real time PCR system (Applied Biosystems) using the SYBR 
green PCR Master Mix (Applied Biosystems). GAPDH was used as an internal control 
to normalize mRNA expression. Each sample was analyzed in triplicate. The primer 
sequences used are summarized below: 
 
NOD1-forward: 5'-CCTGACAAGGTCCGCAAA 
NOD1-reverse: 5’-CACGTAGGCATCTGCGAGT 
RIPK2-forward: 5-CCATTGAGATTTCGCATCCT 
RIPK2-reverse: 5-ATGCGCCACTTTGATAAACC 
TRAF6-forward: 5’-AGCACAGCAGTGCAATGGAAT 
TRAF6-reverse: 5’- CCGGGTTTGCCAGTGTAGAAT 
TAK1-forward: 5’-AGTGATAACGCGTCGGAAAC 
TAK1-reverse: 5’-CAGGCTCTCAATGGGCTTAG 
TIFA-forward: 5’- GTGCATGGTCAGATTCGGAGA 
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TIFA-reverse: 5’-TGGTGGCCAGTTGTTTTCTTG 
GAPDH-forward: 5’-GAAGGT GAAGGTCGGAGTC 
GAPDH-reverse: 5’-GAAGATGGTGATGGGATTTC 
11 Statistical analysis 
Data presented are representative of at least three independent experiments if not 
stated otherwise. Data are expressed as mean ± standard deviation of triplicate 
samples or as indicated in the figure legends. p-values were calculated with a two-tailed 
two-sample equal variance t-test. 
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1. Discussion 
Upon bacterial infection host cells sense various bacterial products present at the 
surface of bacteria or released during infection (PAMPs) as well as the presence of 
miss localized endogenous components (DAMPs). This leads to the activation of 
signaling cascades, which induce the expression of proinflammatory cytokines. Many 
bacterial pathogens interfere with these signaling cascades by injecting effector 
proteins into the host cell cytosol. Shigella flexneri for example injects several effectors 
that suppress pronflammatory signals and thereby block the expression of cytokines 
such as IL-8 in the infected cell. Nevertheless, IL-8 was detected in Shigella infected 
tissues [38]. This suggested that there is a host strategy to counteract the immune-
suppressive activity of bacterial effectors. We recently provided evidence for such a 
strategy. We reported a mechanism of cell–cell communication between consecutive 
epithelial cells that allows S. flexneri infected cells to propagate NF-κB and MAP kinase 
activation to uninfected bystander cells in a gap junction dependent manner. Bystander 
cells subsequently express proinflammatory genes and secrete massive amounts of 
cytokines [39]. Furthermore, we found that triggering of the NOD1 signaling pathway 
with TriDAP was sufficient to induce bystander IL-8 expression, suggesting that the 
recognition of Nod1 ligands in infected cells may be sufficient to generate the 
underlying signals that mediate IL-8 expression in bystander cells of S. flexneri 
infection. 
The goal of this study was to elucidate the molecular mechanism of cell-cell 
communication during S. flexneri infection. In particular, we aimed at finding signaling 
events required in infected cells that trigger bystander IL-8 expression. Furthermore, we 
dissected signaling events taking place in bystander cells of infection that culminate in 
IL-8 production and finally, we aimed at identifying the signaling molecule(s) 
responsible for bystander IL-8 expression. To our surprise, we found that signals 
underlying cell-cell communication during S. flexneri infection were generated 
independently of the activation of the NOD1 signaling pathway and of the activation of 
the two newly identified candidate proteins for bystander activation, TIFA and TRAF6, in 
infected cells. In contrast, in bystander cells of infection the NOD1 signaling pathway 
contributes together with a NOD1 independent signaling pathway to the expression of 
proinflammatory genes. We identified TIFA and TRAF6 as members of this NOD1 
independent pathway. Moreover, C12-iE-DAP stimulation experiments revealed first, 
that NOD1 signaling in bystander cells of infection was not exclusively mediated via the 
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adaptor protein RIPK2 but was partially TIFA and TRAF6 dependent and the signaling 
in bystander cells converge on TAK1. Finally, we show that IP3 induced intercellular 
calcium waves contribute to bystander IL-8 expression. 
1.1 Signaling in infected cells 
Cellular stresses such as bacterial invasion lead to the activation of NF-κB. NF-κB is an 
ubiquitous transcription factor that controls the expression of proinflammatory genes 
including cytokines, acute phase response proteins, and cell adhesion molecules and 
promotes cell survival. Small interfering RNA mediated depletion of NF-κB revealed the 
essential function of this transcription factor during S. flexneri infection. Epithelial cells 
depleted for NF-κB were no longer able to produce IL-8 in response to bacterial 
challenge. A detailed analysis of NF-κB activation in S. flexneri infected and in 
uninfected bystander cells indicated that NF-κB activation was essential in bystander 
cells to control IL-8 expression but was dispensable in infected cells to trigger bystander 
activation. These data suggest that early signaling events in infected cells are 
responsible for bystander activation and not gene expression downstream of NF-κB. 
This was expected due to the observation that NF-κB activation propagated within the 
first 15 minutes of infection to neighboring cells [39]. 
The MAP3 kinase TAK1 is a key element in many signaling pathways that are activated 
in response to environmental stresses [170], including S. flexneri infection. Once 
activated TAK1 in turn activates the IKK complex that mediates NF-κB translocation. 
Moreover, TAK1 activates the MAP kinases p38 and JNK. While p38 acts on histone 
phosphorylation and thereby promotes DNA accessibility for transcription factors, JNK 
activates AP-1 another transcription factor that contributes to proinflammatory gene 
expression. Dissecting the role of TAK1 activation in the process of bystander activation 
during S. flexneri infection pointed to an essential role for this protein complex 
exclusively in bystander cells. Although TAK1 is activated not only in bystander cells but 
also in infected cells, our data clearly showed that TAK1 activation in infected cells was 
dispensable for the production of a signaling molecule that triggers bystander activation. 
This finding excludes a role for the MAP kinases p38 or JNK in infected cells in the 
process of bystander activation. 
Since microinjection of the NOD1 ligand TriDAP was sufficient to trigger bystander IL-8 
expression, we hypothesized that signals underlying bystander activation are generated 
in infected cells in a NOD1 signaling pathway dependent manner. Unexpectedly, 
Discussion and Outlook 
74 
depletion of RIPK2 in HeLa cells or depletion of NOD1 in HEK cells resulted not in a 
complete block of IL-8 expression during S. flexneri infection, implying the existence of 
a NOD1 independent signaling pathway that contributes to bystander IL-8 expression. 
Next, by performing the mixed cell population assay, it became evident that signals in 
infected cells that trigger bystander activation are generated independently of RIPK2 or 
NOD1 signaling. These data indicate that signals that are required for bystander 
activation are produced independent of pathogen recognition by NOD1 or alternatively, 
result from the activation of the NOD1 independent signaling pathway. 
In the genome wide RNAi screen performed by C.A. Kasper, TRAF6 was identified as a 
protein involved in the process of bystander IL-8 expression. TRAF6 turned out to be a 
candidate protein that could be part of a NOD1 independent signaling pathway that 
triggers bystander activation. TRAF6 is an E3 ubiquitin ligase known to activate TAK1 
and NF-κB downstream of various receptors including TLRs and IL-1R [177]. Moreover, 
TRAF6 was shown to be recruited to membrane fragments produced by invading S. 
flexneri [178], which are sensed as DAMPs and induce inflammatory responses. On the 
other hand, Sanada and colleagues showed that TRAF6 activation in S. flexneri 
infected cells was suppressed by the effector protein OspI leading to impaired NF-κB 
activation [140]. We found that TRAF6 was essential for IL-8 expression during S. 
flexneri infection in HeLa cells. In HEK cells over-expressing NOD1 we could not 
observe this strong impact of TRAF6 depletion on NF-κB activation and IL-8 expression 
during infection. This might be due to the over expression of NOD1 in this cell line, 
leading to RIPK2 dependent activation of NF-κB and subsequent IL-8 production. Since 
the NOD1 mRNA level in HeLa cells is comparable to the one of freshly isolated human 
colon epithelial cells [139], data gained in HeLa cells might better reflect the role of 
TRAF6 signaling during S. flexneri infection. Finally, our detailed analysis of TRAF6 
signaling in infected HeLa cells revealed that signals required to trigger bystander IL-8 
expression are generated independently of TRAF6, which is not surprising when 
considering the fact that TRAF6 activation is inhibited by S. flexneri in infected cells. 
TIFA another candidate protein found in the genome wide RNAi screen was as well 
found to be essential for bystander IL-8 expression during S. flexneri infection. So far, 
TIFA was desribed as a TRAF6 interacting protein [179]. TIFA was shown to mediate 
NF-κB and JNK activation, most likely by linking TRAF6 to IRAK1 in the IL-1 signaling 
pathway. In in vitro reconstitution experiments TIFA was found to induce the 
oligomerization and ubiquitination of TRAF6 resulting in the activation of the TAK1 and 
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IKK protein complexes [180]. As for TRAF6 we found that TIFA was not required in 
infected cells to trigger signals underlying bystander activation.  
As the signals, that trigger bystander activation, are apparently produced independently 
of the signaling pathways tested, we addressed the question whether S. flexneri uptake 
into epithelial cells was required for the induction of bystander IL-8 expression or 
whether already the insertion of the T3SS needle and injection of effector proteins was 
sufficient to induce a proinflammatory response. For this purpose HeLa cells were 
treated with cytochalasin D, an inhibitor of actin polymerization thereby preventing the 
dynamic cytoskeletal rearrangements that are necessary for S. flexneri invasion into 
epithelial cells. The IL-8 response of treated cells compared to the IL-8 response of 
untreated control cells was completely abolished, indicating that S. flexneri uptake into 
epithelial cells is essential for the induction of a proinflammatory response (data not 
shown), which raises the question whether actin cytoskeletal rearrangements or 
phagosomal membrane remnants, that act as signaling platforms, might be required to 
trigger bystander IL-8 expression. 
1.2 Signaling in bystander cells 
In this work, signaling events taking place in bystander cells of S. flexneri infected 
epithelial cells were investigated, in order to determine the signaling network that 
mediates the proinflammatory response. Our detailed analysis of signaling events 
taking place in bystander cells of S. flexneri infection indicated, to our surprise, that 
NOD1 and RIPK2 contribute to IL-8 expression exclusively in bystander cells. This was 
unexpected and raises the question how the classical NOD1-RIPK2 pathway is 
activated in bystander cells. The most obvious hypothesis would be that NOD1 ligands 
diffuse from infected to bystander cells and trigger the NOD1 pathway. An alternative 
hypothesis could be that NOD1 detects the activation of small RHO GTPases. It was 
shown that constitutively active RHO GTPases such as RAC1, CDC42 and RHOA were 
sufficient to activate the NOD1-RIPK2 signaling pathway [119]. During S. flexneri 
infection activated ARGEF2, a known activator of RHOA, has been found to potentiate 
NOD1 signaling in infected cells, and the authors of this report observed an increased 
ARGEF2 expression in the cytoplasm of uninfected neighboring cells [120], pointing to 
the possibility that RHOA gets activated in bystander cells and activates the NOD1 
signaling pathway. Preliminary data suggest that RHOA indeed could be activated in 
bystander cells, because inhibition of the RHOA downstream target RHOA kinase 
(ROCK) in bystander cells of S. flexneri infected cells, resulted in an abolished IL-8 
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response. We also tested whether ERK1/2 could be involved in ARHGEF2 activation in 
bystander cells. ERK1/2 is activated in bystander cells of S. flexneri infection and 
recently, ERK1/2 was shown to activate the guanine exchange factor ARHGEF2 
thereby mediating RHOA activation [181]. siRNA mediated depletion of ERK1/2 did not 
result in a decreased number of IL-8 producing bystander cells/infection site (data not 
shown). Since cells depleted for ERK1/2 and stimulated with PMA, an activator of the 
ERK pathway, showed a reduction of IL-8 positive cells of 82% (± 2%) compared to 
control cells, we assumed that siRNA mediated depletion of ERK1/2 worked in this 
experiment. In addition, the impact of MEK1/2 inhibition on IL-8 production in bystander 
cells of S. flexneri infection was tested. MEK1/2 are the MAP2 kinases that activate 
ERK1/2. A slightly reduced IL-8 response was observed, when MEK1/2 was inhibited 
(data not shown). As ERK1/2 is - together with p38 - also involved in histone H3 
phosphorylation, the effect observed might not be attributed to a triggering of NOD1 
signaling in bystander cells. 
The newly identified proteins, TIFA and TRAF6 were as well found to be exclusively 
required in bystander cells for the production of IL-8. To put them into a signaling 
network we monitored TAK1 phosphorylation in bystander cells. It turned out that TAK1 
indeed is activated in bystander cells. Moreover, analysis of TAK1 phosphorylation in 
TIFA or TRAF6 depleted cells revealed that TAK1 activation was strongly TIFA and 
completely TRAF6 dependent, indicating that TIFA and TRAF6 are upstream of TAK1 
and contribute together with NOD1-RIPK2 signaling to TAK1 activation. 
Further analysis of the signaling network in bystander cells by stimulation of TRAF6 
depleted HEK NOD1 over expressing cells with the NOD1 ligand, revealed that NOD1 
signaling to NF-κB in bystander cells was partially TRAF6 dependent, linking TRAF6 to 
the NOD1 signaling pathway in bystander cells of S. flexneri infection. This observation 
is in line with data gained in human periodontal ligament fibroblasts (HPDLFs). HPDLFs 
belong to the peridontal ligament, a tissue that is located at the root end of a tooth. 
Besides connecting the root with the alveolar bone, these cells upon encountering 
bacteria produce several pro-inflammatory cytokines, such as IL-1β, IL-6, and IL-8. iE-
DAP stimulation of HPDLFs depleted for TRAF6 by means of RNA interference, 
resulted in an impaired IL-1β, IL-6, and IL-8 response, indicating as well that NOD1 
signaling involves TRAF6 activity [182]. The TRAF6 interacting protein TIFA was also 
found to contribute to NOD1 signaling in bystander cells of S. flexneri infected cells, but 
to a lesser extent than TRAF6, suggesting that signals activating the NOD1 
independent pathway lead to TIFA dependent TRAF6 activation, which in turn 
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potentiates NOD1 signaling. Finally, because TAK1 depleted cells are no longer able to 
respond to S. flexneri infection or to iE-DAP stimulation, signals apparently converge on 
TAK1 in bystander cells. 
Recently, Huang and colleagues unraveled the molecular mechanism of the TIFA 
dependent activation of TRAF6 upon TNFα stimulation. They identified a threonine 
phosphorylation site (T9) on TIFA that, when phosphorylated, is recognized by the TIFA 
FHA domain [171]. This interaction provokes the self oligomerization of TIFA leading to 
TRAF6 recruitment and activation and subsequent activation of NF-κB. We tested 
whether during S. flexneri TIFA phosphorylation at T9 was required for signaling events 
that lead to IL-8 expression in bystander cells and found that it was indeed the case 
(C.A. Kasper unpublished data). TIFA has so far been linked to signaling pathways 
including IL-1R, TNFR and TLR signaling [171, 179, 183]. We show for the first time, 
that TIFA contributes to NOD1 signaling in bystander cells of S. flexneri infection and 
that TIFA phosphorylation is required for the activation of NF-κB. 
1.3 Signaling molecules 
In our previous study we showed that cell-cell communication during S.flexneri infection 
is not mediated by secretion of signaling molecules, but is strictly dependent on cell-cell 
contact and mediated via gap junctions. Gap junctions are channels formed between 
adjacent cells. Only small and hydrophilic molecules (< 1- 2 kDa) are able to diffuse 
through these channels from cell to cell. The finding that NOD1 signaling was 
exclusively required in bystander cells for IL-8 expression was surprising and implicates 
hat the NOD1 ligand itself might be one of the signaling molecules that induce 
bystander IL-8 expression. The NOD1 minimal ligand iE-DAP is a dipeptide small 
enough to diffuse via gap junctions. Dividing bacteria cleave their peptidoglycan chains 
into smaller monomers or fragments of peptidoglycan. It is estimated that gram-
negative bacteria recycle only 30 – 60% of this peptidoglycan, indicating that during 
replication considerable amounts of peptidoglycan are constantly released into the 
cytosol of host cells [184]. Moreover, analysis of the culture supernatant of Escherichia 
coli K12 strains (which share more than 98% sequence identity with S. flexneri) 
revealed that these bacteria released various NOD1-activating peptidoglycan moieties 
[185] amongst which many are small enough to diffuse via gap junctions. In our 
previous study, bystander activation turned out to be a general mechanism observed in 
response to other enteropathogens such as S. enterica ser. Typhimurium and Listeria 
monocytogenes. Even though L. monocytogenes is a gram-positive pathogen its 
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peptidoglycan contains iE-DAP and was shown to activate NOD1 [90, 186]. Taken 
together these observations support the idea that diffusion of the NOD1 ligand iE-DAP, 
which is released by all kind of pathogens that possess iE-DAP in their peptidoglycan, 
might well be one of the signals that trigger bystander IL-8 expression during bacterial 
infection. 
Interestingly, we observed that S. flexneri infected cells depleted for NOD1 were still 
able to produce IL-8, indicating that a NOD1 independent signaling pathway contributes 
to the induction of the inflammatory response elicited by host cells. In search for such a 
pathway, we decided to investigate whether calcium signaling contributed to bystander 
IL-8 expression for several reasons: First, invading S. flexneri induce intercellular 
calcium signaling that include IP3 dependent calcium release from internal stores [173]. 
Second, calcium and IP3 are two second messengers that are able to diffuse through 
gap junctions. Third, in the field of cell physiology, it is suggested that IP3-induced 
intercellular calcium signaling mediated via gap junctions may represent a general 
mechanism by which cells do communicate over short distances to coordinate their 
activity in physiological and in pathological conditions [158]. And finally, the fact that an 
IL-8 response in epithelial cells induced by the NOD1 ligand iE-DAP could be 
potentiated when calcium signaling was triggered, further supported this idea. Our 
studies confirmed a role for intercellular calcium signaling and for IP3 in the process of 
bystander IL-8 expression. Interestingly, inhibition of intercellular calcium signaling with 
the calcium chelator BABTA-AM or the inhibition of the IP3 receptor with 2-APB, 
exclusively led to a reduced IL-8 response in bystander cells but did not affect NF-κB 
activation indicating that calcium signaling might trigger MAP kinase signaling 
downstream of TAK1, thereby mediating histone phosphorylation and consequently 
DNA accessibility for transcription factors required for proper gene expression. 
Moreover our preliminary data, suggest that PLCγ1 might be responsible for the 
production of IP3 during Shigella infection. Inhibition of this enzyme did again not affect 
NF-κB activation but the IL-8 response in bystander cells was significantly reduced. 
Strikingly, ATP1A1 depleted HeLa cells infected with S. flexneri, showed a similar 
pattern i.e. NF-κB activation not affected combined with a reduced, yet abolished IL-8 
response. The Na+/K+-ATPase is a sodium pump located at plasma membranes. 
However, it was found to act not only as a pump for ions across the plasma membrane 
but also as signal transducing receptor for cardiotonic steroids such as ouabain [187]. 
Activation of the signaling function of ATP1A1 resulted in tyrosin phosphorylation of 
multiple proteins including SRC and EGFR. Furthermore, in co-immunoprecipitation 
Discussion and Outlook 
79 
experiments ATP1A1 was shown to bind to PLCγ1 and to the IP3 receptor leading to 
calcium release from internal stores [188]. Further investigation is required to establish 
the novel role for ATP1A1 in calcium signaling that contributes to a proinflammatory 
response during bacterial infection. 
In our previous study, bystander activation turned out to be a general mechanism 
observed in response to other enteropathogens such as S. enterica ser. Typhimurium 
and Listeria monocytogenes. In a parallel work to ours, bystander activation during L. 
monocytogenes has been studied in an infection model using murine mIC12 cells (small 
intestinal epithelial cells) [163]. Detection of L. monocytogenes was NOD2 dependent. 
Cell-cell propagation of proinflammatory signals was gap junction independent, instead 
it required the production of ROI by the NADPH oxidase NOX4. ROI was detected in 
bystander cells and inhibition of ROI production resulted in abolished bystander CXCL2 
and CXCL5 production. The differences in the mechanisms identified might origin from 
the different cell lines and the different pathogens used as model systems. However, 
the observed differences in the mechanisms of bystander activation between Shigella 
and Listeria could as well indicate that there exist diverse host signaling pathways that 
upon activation mediate bystander activation. 
A mechanism of cell-cell communication based on the diffusion of peptidoglycan 
moieties and IP3 molecules via gap junctions could very well explain the observations 
made during bacterial infection of epithelial cells. Dividing bacteria produce iE-DAP, 
which diffuses to bystander cells and induces the inflammatory response. IP3 induced 
intercellular calcium signaling contribute to the porinflammatory response. Infected cells 
by sensing the bacteria as a stress close their gap junctions thereby terminating cell-cell 
communication. DAP is no longer released from infected cells and by diffusing dilutes 
out until at some point the critical concentration required for NOD1 activation is below 
the limits. IP3 has a short half live and thereby its activity is limited. Thus, a defined 
group of healthy neighboring cells gets signals from a single infected cell and allows the 
host to induce an effective inflammation response resulting in the clearance of infection. 
Further investigation is required to completely elucidate the mechanism of bystander 
activation (Figure IV.1). 
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Taken together, we have shown that signals underlying cell-cell communication during 
S. flexneri infection are generated independently of the NOD1 signaling pathway and of 
the newly identified candidate proteins for bystander activation, TIFA and TRAF6. Our 
detailed analysis of signaling events taking place in bystander cells of S. flexneri 
infection indicate that the NOD1 signaling pathway and a NOD1 independent pathway 
contribute to the induction of proinflammatory gene expression. The newly identified 
signaling proteins TIFA and TRAF6 could be assigned to the NOD1 independent 
pathway and were in addition found to contribute to NOD1 signaling upstream of TAK1 
activation. Furthermore, there is evidence that intercellular calcium signaling induced by 
invasive S. flexneri contribute to the propagation and amplification of the 
proinflammatory response observed during S. flexneri infection. 
 
Figure IV.1 Proposed model of Bystander activation. Intracellular S. flexneri release PDG 
moieties by replicating in the cytosol. PDG might diffuse to bystander cells and activate the 
NOD1 signaling pathway resulting in the expression of proinflammatory genes. In addition, at 
vacuolar membrane remnants, produced by invading S. flexneri, inter cellular calcium signaling 
is triggered, that contributes to proinflammatory gene expression in bystander cells, eventually 
by activating TIFA that signals via TRAF6 to TAK1. (DAG, diacylglycerol; ER, endoplasmatic 
reticulum; IP3, inositol triphosphate; IP3R, IP3 receptor; MAPKs, MAP kinases; PDG, 
peptidoglycan; PIP2, phosphatidylinositol 4,5-bisphosphate; PLCγ1, phospholipase Cγ1) 
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2 Outlook 
2.1 Identification of the signaling molecules required for 
bystander activation 
We identified a NOD1-dependent and a NOD1-independent signaling pathway in 
bystander cells that control the expression of proinflammatory genes during S. flexneri 
infection. The NOD1-dependent pathway in bystander cells most likely gets activated by 
peptidoglycan derived from replicating bacteria representing signal 1, whereas 
intercellular calcium signaling could be the second signal that might trigger the NOD1-
independent pathway in bystander cells. To test this hypothesis, control cells and cells 
depleted for NOD1 should be left untreated or treated with a calcium inhibitor and then 
infected with Shigella, subsequently the activation of NF-κB and the production of IL-8 
should be monitored by immunofluorescence microscopy. In case that calcium signaling 
and stimulation of the NOD pathway together are responsible for bystander IL-8 
expression, inhibitor treated cells depleted for NOD1 would not be able to activate NF-
κB and subsequently no IL-8 could be detected. 
Next, it should be investigated, whether peptidoglycan moieties derived from replicating 
bacteria indeed are able to diffuse via gap junctions to neighboring cells. By 
microinjecting fluorescently labeled iE-DAP, in presence or absence of the gap junction 
inhibitor 18β-GA, the diffusion of the NOD1 ligand from cell to cell, could be monitored 
by fluorescence microscopy. 
If this is the case, the next question would be, whether the amount of diffusible NOD1 
ligands, released by replicating bacteria, is sufficient to trigger NOD1 signaling in 
bystander cells. To test this hypothesis, A431 connexin43 overexpressing cells, which 
allow optimal diffusion via gap junctions, should be infected with wild-type Shigella and 
Shigella ∆mppA, a mutant strain, which is impaired in peptidoglycan recycling [189], 
and the areas covered with IL-8 around infected cells should be monitored by 
immunofluorescence microscopy. If peptidoglycan is signal 1, which diffuses to 
bystander cells to activate the NOD1-dependent pathway, the mutant strain releasing 
bigger amounts of peptidoglycan, should cause significantly bigger areas covered with 
IL-8 compared to wild-type Shigella. 
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2.2 Is NOD1 a sensor for PAMPs and/or DAMPs in bystander 
cells? 
The NOD1 pathway gets activated by sensing of the PAMP iE-DAP and by sensing of 
DAMPs, such as activated RHO GTPases, including RHOA, CDC42 and RAC1 [119]. 
Experiments on iE-DAP diffusion will be one part of the answer how NOD1 might get 
activated in bystander cells. Furthermore, the use of NOD1 mutants, that harbor point 
mutations in the LRR domain, which have been shown to drastically impair iE-DAP 
dependent NOD1 activation [190], might provide a tool to discriminate between iE-DAP 
dependent NOD1 activation and/or DAMP dependent activation of NOD1, given that 
NOD1 acts as scaffolding protein in the latter case, and a functional LRR domain is not 
required for DAMP dependent activation of NOD1. Cells, overexpressing NOD1 
mutants impaired in iE-DAP sensing, should be infected with Shigella and NF-κB 
activation and IL-8 production in bystander cells should be monitored by 
immunofluorescence microscopy. An impaired inflammation response could then point 
to iE-DAP diffusion dependent NOD1 activation in bystander cells. 
It could as well be that NOD1 acts as a DAMP sensor in bystander cells. One possible 
DAMP, which might be present in bystander cells of S. flexneri infected cells, is RHOA, 
because we observed that inhibition of the RHOA downstream target ROCK in 
bystander cells abolishes IL-8 expression. By means of a pull down assay for activated 
RHOA it should be tested, whether RHOA is activated in bystander cells. If this is the 
case, by inhibiting RHOA with pharmacological tools or by RNAi mediated depletion, its 
possible impact on NF-κB activation and IL-8 production in bystander cells should be 
evaluated by immunofluorescence microscopy. 
2.3 What is upstream of TIFA in bystander cells? 
The observation that TIFA phosphorylation of threonine 9 is required during S. flexneri 
infection implies that a serine/threonine kinase is upstream of TIFA. In co-
immunoprecipitation experiments AKT and aurora kinase were identified as candidate 
proteins for TIFA phosphorylation upon TNFα stimulation (Huang, unpublished data) 
and in in vitro kinase assays TIFA phosphorylation was PKC inhibitor sensitive [171]. 
Since we could show, that AKT is exclusively activated in infected cells, AKT cannot be 
the kinase phosphorylating TIFA in bystander cells. Furthermore, no reduction in 
bystander IL-8 expression of S. flexneri infected HeLa cells depleted for aurora kinase 
was observed (C.A. Kasper unpublished data). In contrast, PKC might be a promising 
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candidate protein for TIFA activation in bystander cells, because PKC is activated 
downstream of calcium signaling [191]. In addition, this would link calcium to the NOD1-
independent signaling pathway in bystander cells. Therefore, the effect of PKC 
inhibitors as well as siRNA mediated depletion of PKC on NF-κB activation and on 
bystander IL-8 expression during S. flexneri infection should be tested. 
2.4 What is the role of ATP1A1 (Na+/K+-ATPase)? 
To further characterize the role of ATP1A1 in the process of bystander activation, first a 
possible general defect in protein synthesis should be excluded by monitoring of IL-8 
mRNA in Shigella infected HeLa cells depleted for ATP1A1. If also IL-8 mRNA is 
reduced, the requirement of ATP1A1 in infected and/or in bystander cells should be 
tested in a mixed cell population assay. Furthermore, by means of live cell imaging one 
could test, whether in ATP1A1 depleted cells intercellular calcium signaling is blocked. 
Moreover, ATP1A1 has been found to function as scaffolding protein, bringing PLCγ1 
and the IP3 receptor together to form a signaling complex [188]. The N-terminal tail of 
the catalytic α-subunit (αNT-t) of ATP1A1 was found to mediate this interaction, which 
results in calcium dependent NF-κB activation [192]. To study, whether this interaction 
is required during Shigella infection, small peptides corresponding to αNT-t could be 
overexpressed that are known to interfere with the interaction between ATP1A1 and the 
IP3 receptor, and subsequently abolish calcium dependent NF-κB activation [192]. If 
ATP1A1 acts as a scaffolding protein during Shigella infection, one can expect that NF-
κB activation would not be affected but the IL-8 response would be abolished. 
2.5 What is the role of ROCK during S. flexneri infection? 
During Shigella infection ROCK activation was associated with NF-κB phosphorylation 
and activation in infected cells [120]. As mentioned before, we observed an abolished 
IL-8 response upon inhibition of ROCK with Y-27632 in bystander cells of S. flexneri 
infected cells (data not shown). By depletion of ROCK by RNAi and performing of mixed 
cell population assays the role of ROCK activation in infected and in bystander cells 
could be addressed in more detail. 
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2.6 What is the contribution of the NOD1-dependent and the 
NOD1–independent pathway in bystander cells in 
controlling gene expression? 
To further characterize the complex signaling events taking place in bystander cells 
during S. flexneri infection, it will be of interest to dissect the contribution of the NOD1-
dependent and the NOD1-independent signaling pathways to the expression of 
proinflammatory genes. Proteins of interest can either be depleted by RNAi or inhibited 
by pharmacological tools. Cells will be infected with Shigella or selectively stimulated 
with the NOD1 ligand or with calcium (ionomycin). Then the activation of TAK1, NF-κB, 
p38, JNK and ERK will be monitored by immunoblotting. The signaling patterns of each 
protein, should then allow assigning them to the different signaling pathways. 
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1 Statement of contribution 
I contributed the in situ hybridization, Fig. 4B; infections in Tnfr-/- MEF, Fig. 6A and 
S6A/B; TNFα and GM-CSF in bystander cells, Fig. S4E-G. 
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Abbreviations 
 
AKT  v-akt murine thymoma viral oncogene homolog 
AP-1  activator protein 1 
APC  antigen-presenting cell 
ARP  actin-related protein 
ASC  apoptosis-associated speck like protein 
ATF2  Activating transcription factor 2 
ATP1A1 Na
+
/K
+
-ATPase 
BIR  baculoviral inhibitory repeat 
cAMP  cyclic adenosine monophosphate 
CARD  caspase recruitment domain 
CCL2  chemokine (C-C motif) ligand 2 
CDC42  Cell division control protein 42 
cGAMP  cyclic GMP-AMP 
cGAS  cyclic GMP-AMP (cGAMP) synthase 
cGMP  cyclic guanosine monophosphate 
cIAP  inhibitor of apoptosis protein homolog C 
CLR  C-type lectin receptor 
CX  Connexin 
CXCL  chemokine (C-X-C motif) ligand 
DAG  diacylglycerol 
DAMP  danger-associated molecular pattern 
dsDNA  double-stranded DNA 
E1  ubiquitin activating enzyme 
E2  ubiquitin conjugating enzyme 
E3  ubiquitin ligase 
EGF  epidermal growth factor 
EGFR  EGF receptor 
ER  endoplasmatic reticulum 
ERK  extracellular signal-regulated kinase 
FAE  follicle associated eithelium 
F-actin  filamentous actin 
FHA  forkhead-associated domain 
GEF  guanine-nucleotide exchange factor 
GFP  green fluorescent protein 
GJIC  gap junctional intercellular communication 
GM-CSF Granulocyte macrophage colony-stimulating factor 
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GTP  Guanosintriphosphat 
HIV  human immunodeficiency virus 
IAP  inhibitor of apoptosis protein 
IEC  intestinal epithelial cell 
iE-DAP  γ-D-glutamyl-meso-diaminopimelic acid 
IκBα  inhibitor of NF-κB 
IL  interleukin 
IL-8  interleukin 8 
IKK  inhibitor of κ light polypeptide gene enhancer in B-cells kinase 
INF  interferon 
IP3  inositol trisphosphate 
Ipa  invasion plasmid antigens 
Ipg  invasion plasmid gene 
IRAK  IL-1 receptor-associated kinase 
IRF  interferon regulatory factor 
JNK  JUN N-terminal kinase 
LC-HRMS liquid chromatography high resolution mass spectrometry 
LPS  lipopolysaccharide 
LRR  leucine-rich repeat 
M-cells   microfold cells 
MAP2 kinase mitogen-activated protein kinase kinase 
MAP3 kinase mitogen-activated protein kinase kinase kinase 
MAP kinase mitogen-activated protein kinase 
MD-2  myeloid differentiation protein-2 
MDP  muramyl dipeptide 
MOI  multiplicity of infection 
MSK  mitogen- and stress-activated kinase 
Mxi  membrane expression of Ipa 
MYD88  myeloid differentiation primary response gene (88) 
NACHT  domain has been named after NAIP, CIITA, HET-E and TP-1; also called NOD 
NAD  NACHT-associated domain 
NF-κB  nuclear factor of κ light polypeptide gene enhancer in B-cells 
NK  natural killer 
NOX4  NADPH oxidase 
NLR  Nod-like receptor 
NLRA  acidic domain containing NLR 
NLRB  BIR domain containing NLR 
NLRC  CARD domain containing NLR 
NLRP  pyrin domain containing NLR 
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NLRX  no strong N-terminal homology NLR 
NOD  nucleotide-binding and oligomerization domain; also called NACHT 
N-WASP neural Wiskott-Aldrich syndrome protein 
Osp  outer Shigella proteins 
PAI  pathogenicity Island 
PAMP  pathogen-associated molecular pattern 
PDG  peptidoglycan 
PI3K  phosphoinositide-3-kinase 
PI5P  phosphatidylinositol 5-phosphate 
PIP2  phosphatidylinositol 4,5-bisphosphate 
PKA  protein kinase A 
PKC  protein kinase C 
PKG  protein kinase G 
PLC γ1  phospholipase Cγ1 
PMN  polymorphnuclear cell 
PRR  pathogen recognition receptor 
PYD  pyrin domain 
RAC  ras-related C3 botulinum toxin substrate 
RHO  ras homolog 
RIPK2  receptor-interacting protein 2 
RLR  RIG-I-like receptor 
RNAi  RNA interference 
ROS  reactive oxygen species 
SARM  sterile alpha and HEAT-Armadillo motifs  
siRNA  small interfering RNA 
Spa  surface presentation of antigen 
SRC  v-src sarcoma viral oncogene homolog 
ssRNA  single-stranded RNA 
T3SS  type 3 secretion system 
TAK1  TGFβ-activated kinase  
TAB  TAK1-binding protein 
TIFA  TRAF-interacting protein with a forkhead-associated (FHA) domain 
TIR  Toll-IL-1 receptor 
TLR  Toll-like receptor 
TNF  tumor necrosis factor 
TRAF  TNF receptor-associated factor 
TRAM  TRIF-related adaptor molecule 
TriDAP  L-alanyl-γ-D-glutamyl-meso-diaminopimelic acid 
TRIF  TIR domain containing adaptor inducing interferon-β 
Abbreviations 
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WHO  World Health Organization 
XIAP  X-linked inhibitor of apoptosis protein  
ZO  zonula occludens 
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